CN116969937A - Bcl-2抑制剂 - Google Patents
Bcl-2抑制剂 Download PDFInfo
- Publication number
- CN116969937A CN116969937A CN202310560508.6A CN202310560508A CN116969937A CN 116969937 A CN116969937 A CN 116969937A CN 202310560508 A CN202310560508 A CN 202310560508A CN 116969937 A CN116969937 A CN 116969937A
- Authority
- CN
- China
- Prior art keywords
- azaspiro
- isopropylphenyl
- nonane
- butyl
- mmol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940123711 Bcl2 inhibitor Drugs 0.000 title description 8
- 239000012664 BCL-2-inhibitor Substances 0.000 title description 7
- 150000001875 compounds Chemical class 0.000 claims abstract description 100
- 238000000034 method Methods 0.000 claims abstract description 47
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 32
- 201000010099 disease Diseases 0.000 claims abstract description 22
- 230000001640 apoptogenic effect Effects 0.000 claims abstract description 6
- 230000002074 deregulated effect Effects 0.000 claims abstract description 6
- -1 -C 3-10 Cycloalkyl Chemical group 0.000 claims description 552
- 125000000623 heterocyclic group Chemical group 0.000 claims description 78
- 125000000217 alkyl group Chemical group 0.000 claims description 77
- 125000003118 aryl group Chemical group 0.000 claims description 37
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 34
- 125000005605 benzo group Chemical group 0.000 claims description 33
- 229910052739 hydrogen Inorganic materials 0.000 claims description 33
- 239000001257 hydrogen Substances 0.000 claims description 33
- 125000001072 heteroaryl group Chemical group 0.000 claims description 30
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 29
- 125000001424 substituent group Chemical group 0.000 claims description 25
- 229910052736 halogen Inorganic materials 0.000 claims description 24
- 150000002367 halogens Chemical group 0.000 claims description 24
- 125000003342 alkenyl group Chemical group 0.000 claims description 23
- 150000003839 salts Chemical class 0.000 claims description 22
- 125000000304 alkynyl group Chemical group 0.000 claims description 21
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 20
- 125000003545 alkoxy group Chemical group 0.000 claims description 18
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 16
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 14
- 125000001475 halogen functional group Chemical group 0.000 claims description 14
- 238000006467 substitution reaction Methods 0.000 claims description 14
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 13
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 11
- 239000008194 pharmaceutical composition Substances 0.000 claims description 11
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 9
- 150000002431 hydrogen Chemical class 0.000 claims description 9
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 9
- 125000004043 oxo group Chemical group O=* 0.000 claims description 6
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 5
- 125000002541 furyl group Chemical group 0.000 claims description 5
- 125000005843 halogen group Chemical group 0.000 claims description 5
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 5
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims description 4
- 125000001153 fluoro group Chemical group F* 0.000 claims description 4
- 125000000842 isoxazolyl group Chemical group 0.000 claims description 4
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 4
- 125000004076 pyridyl group Chemical group 0.000 claims description 4
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 3
- 125000001064 morpholinomethyl group Chemical group [H]C([H])(*)N1C([H])([H])C([H])([H])OC([H])([H])C1([H])[H] 0.000 claims description 2
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 abstract description 31
- 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 abstract description 29
- 102220346888 c.307G>T Human genes 0.000 abstract description 7
- 230000002401 inhibitory effect Effects 0.000 abstract description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 518
- 239000000203 mixture Substances 0.000 description 483
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 346
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 341
- 239000000243 solution Substances 0.000 description 310
- 239000011734 sodium Substances 0.000 description 271
- 230000002829 reductive effect Effects 0.000 description 242
- 235000019439 ethyl acetate Nutrition 0.000 description 172
- 238000005481 NMR spectroscopy Methods 0.000 description 162
- 239000012267 brine Substances 0.000 description 158
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 157
- DMUXSGAKEXSNGN-UHFFFAOYSA-N 2-ethyloctanoic acid Chemical compound CCCCCCC(CC)C(O)=O DMUXSGAKEXSNGN-UHFFFAOYSA-N 0.000 description 150
- 239000000543 intermediate Substances 0.000 description 145
- 239000007787 solid Substances 0.000 description 144
- 239000003921 oil Substances 0.000 description 143
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 131
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 114
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 113
- 238000004440 column chromatography Methods 0.000 description 106
- 239000003480 eluent Substances 0.000 description 104
- 239000012044 organic layer Substances 0.000 description 104
- 239000000741 silica gel Substances 0.000 description 103
- 229910002027 silica gel Inorganic materials 0.000 description 103
- 239000004698 Polyethylene Substances 0.000 description 102
- 239000011541 reaction mixture Substances 0.000 description 102
- YMWUJEATGCHHMB-UHFFFAOYSA-N dichloromethane Natural products ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 101
- 239000012074 organic phase Substances 0.000 description 95
- 229920006395 saturated elastomer Polymers 0.000 description 86
- 238000006243 chemical reaction Methods 0.000 description 84
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 76
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 76
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 76
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 68
- ZCYXXKJEDCHMGH-UHFFFAOYSA-N nonane Chemical compound CCCC[CH]CCCC ZCYXXKJEDCHMGH-UHFFFAOYSA-N 0.000 description 64
- BKIMMITUMNQMOS-UHFFFAOYSA-N normal nonane Natural products CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 description 64
- 238000000746 purification Methods 0.000 description 54
- 239000012043 crude product Substances 0.000 description 50
- 239000000460 chlorine Substances 0.000 description 43
- 125000005842 heteroatom Chemical group 0.000 description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 31
- 230000015572 biosynthetic process Effects 0.000 description 29
- 238000003786 synthesis reaction Methods 0.000 description 29
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 27
- 239000002904 solvent Substances 0.000 description 26
- 125000002950 monocyclic group Chemical group 0.000 description 25
- 238000001816 cooling Methods 0.000 description 23
- 229910052760 oxygen Inorganic materials 0.000 description 23
- 238000002953 preparative HPLC Methods 0.000 description 23
- 229910004373 HOAc Inorganic materials 0.000 description 22
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 22
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 21
- 238000003756 stirring Methods 0.000 description 21
- 125000002619 bicyclic group Chemical group 0.000 description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 229910052717 sulfur Inorganic materials 0.000 description 18
- 229910052757 nitrogen Inorganic materials 0.000 description 17
- 239000001301 oxygen Substances 0.000 description 16
- 238000003820 Medium-pressure liquid chromatography Methods 0.000 description 15
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 14
- 229910052799 carbon Inorganic materials 0.000 description 14
- 230000035772 mutation Effects 0.000 description 14
- 238000004808 supercritical fluid chromatography Methods 0.000 description 14
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 13
- 206010028980 Neoplasm Diseases 0.000 description 13
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 13
- 125000004432 carbon atom Chemical group C* 0.000 description 13
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 13
- 239000000706 filtrate Substances 0.000 description 13
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 11
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 10
- 201000011510 cancer Diseases 0.000 description 10
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 10
- 208000035475 disorder Diseases 0.000 description 10
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 10
- 230000014759 maintenance of location Effects 0.000 description 10
- 239000012071 phase Substances 0.000 description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 9
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 9
- GVHWFXNONFYORH-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(C(CNC1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(C(CNC1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C GVHWFXNONFYORH-UHFFFAOYSA-N 0.000 description 8
- 239000008346 aqueous phase Substances 0.000 description 8
- 125000004429 atom Chemical group 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- 239000010410 layer Substances 0.000 description 8
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 8
- 102220025226 rs74315455 Human genes 0.000 description 8
- 239000011593 sulfur Chemical group 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 7
- 239000011737 fluorine Substances 0.000 description 7
- 229910052731 fluorine Inorganic materials 0.000 description 7
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 229910000104 sodium hydride Inorganic materials 0.000 description 7
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 6
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 6
- 229910052794 bromium Inorganic materials 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 229910052801 chlorine Inorganic materials 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 125000004430 oxygen atom Chemical group O* 0.000 description 6
- 238000010791 quenching Methods 0.000 description 6
- 125000006276 2-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C(*)C([H])=C1[H] 0.000 description 5
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 5
- WXSFUHRFTJTOCA-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCNC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCNC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C WXSFUHRFTJTOCA-UHFFFAOYSA-N 0.000 description 5
- 240000001414 Eucalyptus viminalis Species 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 150000004945 aromatic hydrocarbons Chemical group 0.000 description 5
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 5
- 239000012230 colorless oil Substances 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 5
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 5
- 125000003367 polycyclic group Chemical group 0.000 description 5
- 230000000861 pro-apoptotic effect Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- 125000006413 ring segment Chemical group 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- DTUGHJZKCKSVEO-UHFFFAOYSA-N 1-bromo-2-cyclopropylbenzene Chemical compound BrC1=CC=CC=C1C1CC1 DTUGHJZKCKSVEO-UHFFFAOYSA-N 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 4
- LWRSYTXEQUUTKW-UHFFFAOYSA-N 2,4-dimethoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C(OC)=C1 LWRSYTXEQUUTKW-UHFFFAOYSA-N 0.000 description 4
- 125000004938 5-pyridyl group Chemical group N1=CC=CC(=C1)* 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 4
- BZKFMUIJRXWWQK-UHFFFAOYSA-N Cyclopentenone Chemical compound O=C1CCC=C1 BZKFMUIJRXWWQK-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
- 239000007821 HATU Substances 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- 108010090931 Proto-Oncogene Proteins c-bcl-2 Proteins 0.000 description 4
- 102000013535 Proto-Oncogene Proteins c-bcl-2 Human genes 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 229910000085 borane Inorganic materials 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Chemical compound CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 201000003444 follicular lymphoma Diseases 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000012458 free base Substances 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 208000004235 neutropenia Diseases 0.000 description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 description 4
- 125000006299 oxetan-3-yl group Chemical group [H]C1([H])OC([H])([H])C1([H])* 0.000 description 4
- 125000003566 oxetanyl group Chemical group 0.000 description 4
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 4
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 4
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 4
- HLYZSCOMSOYEHF-UHFFFAOYSA-N (1-cyclopropylpyrazol-4-yl)methanol Chemical compound C1=C(CO)C=NN1C1CC1 HLYZSCOMSOYEHF-UHFFFAOYSA-N 0.000 description 3
- INMQDURGNQFXFO-UHFFFAOYSA-N (3-methoxy-1-methylpyrazol-4-yl)methanol Chemical compound COC1=NN(C)C=C1CO INMQDURGNQFXFO-UHFFFAOYSA-N 0.000 description 3
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 3
- JAAJQSRLGAYGKZ-UHFFFAOYSA-N 1,2,3,4-tetrahydronaphthalen-1-ol Chemical compound C1=CC=C2C(O)CCCC2=C1 JAAJQSRLGAYGKZ-UHFFFAOYSA-N 0.000 description 3
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 3
- DJFWBXZNNOYGAU-UHFFFAOYSA-N 1-bromo-1,2,3,4-tetrahydronaphthalene Chemical compound C1=CC=C2C(Br)CCCC2=C1 DJFWBXZNNOYGAU-UHFFFAOYSA-N 0.000 description 3
- KHABDBBXXQVOHP-UHFFFAOYSA-N 1-cyclopropylpyrazole-4-carbaldehyde Chemical compound C1=C(C=O)C=NN1C1CC1 KHABDBBXXQVOHP-UHFFFAOYSA-N 0.000 description 3
- UUZRIAGCTHKQSP-UHFFFAOYSA-N 1-phenylbut-2-yn-1-ol Chemical compound CC#CC(O)C1=CC=CC=C1 UUZRIAGCTHKQSP-UHFFFAOYSA-N 0.000 description 3
- DTALCVXXATYTQJ-UHFFFAOYSA-N 2-propan-2-ylbenzaldehyde Chemical compound CC(C)C1=CC=CC=C1C=O DTALCVXXATYTQJ-UHFFFAOYSA-N 0.000 description 3
- ABAPCDWXFHBYPE-UHFFFAOYSA-N 3,4-dihydro-2h-chromene-4-carbonitrile Chemical compound C1=CC=C2C(C#N)CCOC2=C1 ABAPCDWXFHBYPE-UHFFFAOYSA-N 0.000 description 3
- RGWHTTALQBHDGZ-UHFFFAOYSA-N 3,4-dihydro-2h-chromene-4-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)CCOC2=C1 RGWHTTALQBHDGZ-UHFFFAOYSA-N 0.000 description 3
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 3
- QIDULJWOAIZUJH-UHFFFAOYSA-N 3-methoxy-1-methylpyrazole-4-carbaldehyde Chemical compound COC1=NN(C)C=C1C=O QIDULJWOAIZUJH-UHFFFAOYSA-N 0.000 description 3
- MFBXYJLOYZMFIN-UHFFFAOYSA-N 3-phenylcyclopentan-1-one Chemical compound C1C(=O)CCC1C1=CC=CC=C1 MFBXYJLOYZMFIN-UHFFFAOYSA-N 0.000 description 3
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 3
- BQWSBOWPLAWXAO-UHFFFAOYSA-N 5,6,7,8-tetrahydronaphthalene-1-carbaldehyde Chemical compound C1CCCC2=C1C=CC=C2C=O BQWSBOWPLAWXAO-UHFFFAOYSA-N 0.000 description 3
- NYNSNUNMTUNAEO-UHFFFAOYSA-N 5,6,7,8-tetrahydronaphthalene-2-carbaldehyde Chemical compound C1CCCC2=CC(C=O)=CC=C21 NYNSNUNMTUNAEO-UHFFFAOYSA-N 0.000 description 3
- NVZWMJWMTWOVNJ-UHFFFAOYSA-N 6-azaspiro[3.4]octane Chemical compound C1CCC21CNCC2 NVZWMJWMTWOVNJ-UHFFFAOYSA-N 0.000 description 3
- NPWMTJMDBYTZIZ-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(C=CC(C1)=O)C(=O)OCC1=CC=CC=C1 Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(C=CC(C1)=O)C(=O)OCC1=CC=CC=C1 NPWMTJMDBYTZIZ-UHFFFAOYSA-N 0.000 description 3
- FPHGWFYUXMBTSS-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCC(C1)=O)C(=O)OCC1=CC=CC=C1 Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCC(C1)=O)C(=O)OCC1=CC=CC=C1 FPHGWFYUXMBTSS-UHFFFAOYSA-N 0.000 description 3
- VQTPHHVBFFXHKK-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1=O)CCOC)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1=O)CCOC)C(=O)OC(C)(C)C VQTPHHVBFFXHKK-UHFFFAOYSA-N 0.000 description 3
- LZXZAQHOXZVELV-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCNC1=O)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCNC1=O)C(=O)OC(C)(C)C LZXZAQHOXZVELV-UHFFFAOYSA-N 0.000 description 3
- QQRQHSGXNFMUIR-UHFFFAOYSA-N C(C)N1C(C(NCC1)C1=C(C=CC=C1)C(C)C)=O Chemical compound C(C)N1C(C(NCC1)C1=C(C=CC=C1)C(C)C)=O QQRQHSGXNFMUIR-UHFFFAOYSA-N 0.000 description 3
- YORFHOHVYVVAGE-UHFFFAOYSA-N C(C1=CC=CC=C1)C1CC(NCC1)C1=C(C=CC=C1)C(C)C Chemical compound C(C1=CC=CC=C1)C1CC(NCC1)C1=C(C=CC=C1)C(C)C YORFHOHVYVVAGE-UHFFFAOYSA-N 0.000 description 3
- FDQJTNZOQKYGPH-UHFFFAOYSA-N C1(CC1)C1=C(C=CC=C1)C1N(C=CC(C1)=O)C(=O)OCC1=CC=CC=C1 Chemical compound C1(CC1)C1=C(C=CC=C1)C1N(C=CC(C1)=O)C(=O)OCC1=CC=CC=C1 FDQJTNZOQKYGPH-UHFFFAOYSA-N 0.000 description 3
- YOIIFRULWMURQZ-UHFFFAOYSA-N C1(CC1)C1=C(C=CC=C1)C1N(CCC(C1)=O)C(=O)OCC1=CC=CC=C1 Chemical compound C1(CC1)C1=C(C=CC=C1)C1N(CCC(C1)=O)C(=O)OCC1=CC=CC=C1 YOIIFRULWMURQZ-UHFFFAOYSA-N 0.000 description 3
- USFSFWCLXVMHMT-UHFFFAOYSA-N COC1=CC=C(CN2CC(N(CC2)C(=O)OC(C)(C)C)=O)C=C1 Chemical compound COC1=CC=C(CN2CC(N(CC2)C(=O)OC(C)(C)C)=O)C=C1 USFSFWCLXVMHMT-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 3
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000002424 anti-apoptotic effect Effects 0.000 description 3
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 125000002837 carbocyclic group Chemical group 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 150000002430 hydrocarbons Chemical group 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 3
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 125000004193 piperazinyl group Chemical group 0.000 description 3
- DNUTZBZXLPWRJG-UHFFFAOYSA-M piperidine-1-carboxylate Chemical compound [O-]C(=O)N1CCCCC1 DNUTZBZXLPWRJG-UHFFFAOYSA-M 0.000 description 3
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000002062 proliferating effect Effects 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 125000000168 pyrrolyl group Chemical group 0.000 description 3
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 125000004434 sulfur atom Chemical group 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- 239000003643 water by type Substances 0.000 description 3
- HVRUGFJYCAFAAN-UHFFFAOYSA-N 1-bromo-2-ethylbenzene Chemical compound CCC1=CC=CC=C1Br HVRUGFJYCAFAAN-UHFFFAOYSA-N 0.000 description 2
- OIRHKGBNGGSCGS-UHFFFAOYSA-N 1-bromo-2-iodobenzene Chemical compound BrC1=CC=CC=C1I OIRHKGBNGGSCGS-UHFFFAOYSA-N 0.000 description 2
- LECYCYNAEJDSIL-UHFFFAOYSA-N 1-bromo-2-propan-2-ylbenzene Chemical compound CC(C)C1=CC=CC=C1Br LECYCYNAEJDSIL-UHFFFAOYSA-N 0.000 description 2
- MYFZXSOYJVWTBL-UHFFFAOYSA-N 1-methylpyrazole-4-carbaldehyde Chemical compound CN1C=C(C=O)C=N1 MYFZXSOYJVWTBL-UHFFFAOYSA-N 0.000 description 2
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 2
- FJJYHTVHBVXEEQ-UHFFFAOYSA-N 2,2-dimethylpropanal Chemical compound CC(C)(C)C=O FJJYHTVHBVXEEQ-UHFFFAOYSA-N 0.000 description 2
- JIVGSHFYXPRRSZ-UHFFFAOYSA-N 2,3-dimethoxybenzaldehyde Chemical compound COC1=CC=CC(C=O)=C1OC JIVGSHFYXPRRSZ-UHFFFAOYSA-N 0.000 description 2
- PKZJLOCLABXVMC-UHFFFAOYSA-N 2-Methoxybenzaldehyde Chemical compound COC1=CC=CC=C1C=O PKZJLOCLABXVMC-UHFFFAOYSA-N 0.000 description 2
- NKBWMBRPILTCRD-UHFFFAOYSA-N 2-Methylheptanoic acid Chemical compound CCCCCC(C)C(O)=O NKBWMBRPILTCRD-UHFFFAOYSA-N 0.000 description 2
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 2
- OPHQOIGEOHXOGX-UHFFFAOYSA-N 3,4,5-trimethoxybenzaldehyde Chemical compound COC1=CC(C=O)=CC(OC)=C1OC OPHQOIGEOHXOGX-UHFFFAOYSA-N 0.000 description 2
- JPHKMYXKNKLNDF-UHFFFAOYSA-N 3,4-difluorobenzaldehyde Chemical compound FC1=CC=C(C=O)C=C1F JPHKMYXKNKLNDF-UHFFFAOYSA-N 0.000 description 2
- VFZRZRDOXPRTSC-UHFFFAOYSA-N 3,5-Dimethoxybenzaldehyde Chemical compound COC1=CC(OC)=CC(C=O)=C1 VFZRZRDOXPRTSC-UHFFFAOYSA-N 0.000 description 2
- NNEAKBWZBQOQDH-UHFFFAOYSA-N 3-(1h-inden-2-yl)pyridine Chemical compound C=1C2=CC=CC=C2CC=1C1=CC=CN=C1 NNEAKBWZBQOQDH-UHFFFAOYSA-N 0.000 description 2
- BXVGGHJBRCDSGU-UHFFFAOYSA-N 3-(4-methoxyphenyl)cyclopentan-1-one Chemical compound C1=CC(OC)=CC=C1C1CC(=O)CC1 BXVGGHJBRCDSGU-UHFFFAOYSA-N 0.000 description 2
- WMPDAIZRQDCGFH-UHFFFAOYSA-N 3-methoxybenzaldehyde Chemical compound COC1=CC=CC(C=O)=C1 WMPDAIZRQDCGFH-UHFFFAOYSA-N 0.000 description 2
- 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- ZMMQLFXRGHSTSW-UHFFFAOYSA-N 4-(4-methoxyphenyl)cyclohexan-1-one Chemical compound C1=CC(OC)=CC=C1C1CCC(=O)CC1 ZMMQLFXRGHSTSW-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- KPEJNIIMKXQFNE-UHFFFAOYSA-N 4-[(4-methoxyphenyl)methyl]piperazin-2-one Chemical compound COC1=CC=C(CN2CC(NCC2)=O)C=C1 KPEJNIIMKXQFNE-UHFFFAOYSA-N 0.000 description 2
- AVPYQKSLYISFPO-UHFFFAOYSA-N 4-chlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C=C1 AVPYQKSLYISFPO-UHFFFAOYSA-N 0.000 description 2
- UOQXIWFBQSVDPP-UHFFFAOYSA-N 4-fluorobenzaldehyde Chemical compound FC1=CC=C(C=O)C=C1 UOQXIWFBQSVDPP-UHFFFAOYSA-N 0.000 description 2
- ZEYHEAKUIGZSGI-UHFFFAOYSA-N 4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1 ZEYHEAKUIGZSGI-UHFFFAOYSA-N 0.000 description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 2
- XQABVLBGNWBWIV-UHFFFAOYSA-N 4-methoxypyridine Chemical compound COC1=CC=NC=C1 XQABVLBGNWBWIV-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 101150017888 Bcl2 gene Proteins 0.000 description 2
- ZWCLZNVKCKLLEK-UHFFFAOYSA-N BrC1=C(C=CC=C1)C1CN(CCN1)CC1=CC=C(C=C1)OC Chemical compound BrC1=C(C=CC=C1)C1CN(CCN1)CC1=CC=C(C=C1)OC ZWCLZNVKCKLLEK-UHFFFAOYSA-N 0.000 description 2
- HNCAWYJUXIGVQE-UHFFFAOYSA-N C(C(C)C)C1=C(C=CC=C1)C1CN(CCN1)CC1=CC=C(C=C1)OC Chemical compound C(C(C)C)C1=C(C=CC=C1)C1CN(CCN1)CC1=CC=C(C=C1)OC HNCAWYJUXIGVQE-UHFFFAOYSA-N 0.000 description 2
- ZJDMGPBWIOHXHW-UHFFFAOYSA-N C(C(C)C)N1C(C(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C)=O Chemical compound C(C(C)C)N1C(C(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C)=O ZJDMGPBWIOHXHW-UHFFFAOYSA-N 0.000 description 2
- QNDGGRLXPCLCBN-UHFFFAOYSA-N C(C)(C)(C)S(=O)NC(CNS(=O)(=O)C1=CC=C(C=C1)C)C1=C(C=CC=C1)C(C)C Chemical compound C(C)(C)(C)S(=O)NC(CNS(=O)(=O)C1=CC=C(C=C1)C)C1=C(C=CC=C1)C(C)C QNDGGRLXPCLCBN-UHFFFAOYSA-N 0.000 description 2
- ZGUWIUYPCJZZLX-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C(C[N+](=O)[O-])NS(=O)C(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C(C[N+](=O)[O-])NS(=O)C(C)(C)C ZGUWIUYPCJZZLX-UHFFFAOYSA-N 0.000 description 2
- LDJJCNNJCLDPKW-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1C(N(CCN1)C1=CC=CC=C1)=O Chemical compound C(C)(C)C1=C(C=CC=C1)C1C(N(CCN1)C1=CC=CC=C1)=O LDJJCNNJCLDPKW-UHFFFAOYSA-N 0.000 description 2
- UWIHNJCSMPMBIE-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1C(N(CCN1)CCOC)=O Chemical compound C(C)(C)C1=C(C=CC=C1)C1C(N(CCN1)CCOC)=O UWIHNJCSMPMBIE-UHFFFAOYSA-N 0.000 description 2
- CIBISUBQDDQRPO-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1CN(CCN1C1CC2(C1)CCNCC2)C(=O)C1=CC=C(C=C1)OC Chemical compound C(C)(C)C1=C(C=CC=C1)C1CN(CCN1C1CC2(C1)CCNCC2)C(=O)C1=CC=C(C=C1)OC CIBISUBQDDQRPO-UHFFFAOYSA-N 0.000 description 2
- CYBSDVSXABPEPG-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1CN(CCN1C1CC2(C1)CCNCC2)C(=O)C1=CC=CC=C1 Chemical compound C(C)(C)C1=C(C=CC=C1)C1CN(CCN1C1CC2(C1)CCNCC2)C(=O)C1=CC=CC=C1 CYBSDVSXABPEPG-UHFFFAOYSA-N 0.000 description 2
- QHZKZTTYLWOYNH-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)C(C)C1=CC=CC=C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)C(C)C1=CC=CC=C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C QHZKZTTYLWOYNH-UHFFFAOYSA-N 0.000 description 2
- FZQDEWATYCATKK-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)C1CC(CC1)C1=CC=CC=C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)C1CC(CC1)C1=CC=CC=C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C FZQDEWATYCATKK-UHFFFAOYSA-N 0.000 description 2
- YNOLFVSNPWBTNM-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)C1CCC(CC1)C1=CC=C(C=C1)OC)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)C1CCC(CC1)C1=CC=C(C=C1)OC)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C YNOLFVSNPWBTNM-UHFFFAOYSA-N 0.000 description 2
- BPUOQQHXYWEHHY-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)C1CCCC2=CC=CC=C12)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)C1CCCC2=CC=CC=C12)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C BPUOQQHXYWEHHY-UHFFFAOYSA-N 0.000 description 2
- DUUSNGDGTBODAV-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)CC(C)(C)C)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)CC(C)(C)C)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C DUUSNGDGTBODAV-UHFFFAOYSA-N 0.000 description 2
- AQJMVONIAHWSFX-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)CC1=CC(=C(C(=C1)OC)OC)OC)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)CC1=CC(=C(C(=C1)OC)OC)OC)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C AQJMVONIAHWSFX-UHFFFAOYSA-N 0.000 description 2
- GNOWAKXFHCYLKE-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)CC1=CC=C(C=C1)C(F)(F)F)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)CC1=CC=C(C=C1)C(F)(F)F)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C GNOWAKXFHCYLKE-UHFFFAOYSA-N 0.000 description 2
- QFXHOOAJPXVOQC-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)CC1=CC=C(C=C1)C)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)CC1=CC=C(C=C1)C)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C QFXHOOAJPXVOQC-UHFFFAOYSA-N 0.000 description 2
- MPBFBSNSCUGMSX-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)CC1=CC=C(C=C1)OC(F)(F)F)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)CC1=CC=C(C=C1)OC(F)(F)F)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C MPBFBSNSCUGMSX-UHFFFAOYSA-N 0.000 description 2
- LRSNMFPBHYSNPR-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)CCC1=CC=C(C=C1)OC)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)CCC1=CC=C(C=C1)OC)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C LRSNMFPBHYSNPR-UHFFFAOYSA-N 0.000 description 2
- WMELDEUILIHLKA-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)S(=O)(=O)C)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)S(=O)(=O)C)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C WMELDEUILIHLKA-UHFFFAOYSA-N 0.000 description 2
- WMTXBSHXAWHIJK-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)S(=O)(=O)C1=CC=CC=C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)S(=O)(=O)C1=CC=CC=C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C WMTXBSHXAWHIJK-UHFFFAOYSA-N 0.000 description 2
- AMHKIUOXMOXKJW-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCC(C1)OC1=CC=CC=C1)C(=O)OCC1=CC=CC=C1 Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCC(C1)OC1=CC=CC=C1)C(=O)OCC1=CC=CC=C1 AMHKIUOXMOXKJW-UHFFFAOYSA-N 0.000 description 2
- XZPKERBCCYANMF-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)C1=CC=CC=C1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)C1=CC=CC=C1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C XZPKERBCCYANMF-UHFFFAOYSA-N 0.000 description 2
- MEJOSFFPFXJCDW-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1=O)C1=CC=CC=C1)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1=O)C1=CC=CC=C1)C(=O)OC(C)(C)C MEJOSFFPFXJCDW-UHFFFAOYSA-N 0.000 description 2
- KYDYLBLWJFXATE-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1=O)C1=CC=CC=C1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1=O)C1=CC=CC=C1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C KYDYLBLWJFXATE-UHFFFAOYSA-N 0.000 description 2
- IRLZICLMOQURKN-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1=O)CCOC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1=O)CCOC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C IRLZICLMOQURKN-UHFFFAOYSA-N 0.000 description 2
- AXWQCCIDXFGFTH-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1NCCC(C1)OC1=CC=CC=C1 Chemical compound C(C)(C)C1=C(C=CC=C1)C1NCCC(C1)OC1=CC=CC=C1 AXWQCCIDXFGFTH-UHFFFAOYSA-N 0.000 description 2
- AFUWZEVPGMHGQQ-XNTDXEJSSA-N C(C)(C)C1=C(\C=N\S(=O)C(C)(C)C)C=CC=C1 Chemical compound C(C)(C)C1=C(\C=N\S(=O)C(C)(C)C)C=CC=C1 AFUWZEVPGMHGQQ-XNTDXEJSSA-N 0.000 description 2
- VTLWZCDHKRDYHS-UHFFFAOYSA-N C(C)C1=C(C=CC=C1)C1CN(CCN1)CC1=CC=C(C=C1)OC Chemical compound C(C)C1=C(C=CC=C1)C1CN(CCN1)CC1=CC=C(C=C1)OC VTLWZCDHKRDYHS-UHFFFAOYSA-N 0.000 description 2
- DNUSRZGZVDICAQ-UHFFFAOYSA-N C(C)N1C(C(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C)=O Chemical compound C(C)N1C(C(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C)=O DNUSRZGZVDICAQ-UHFFFAOYSA-N 0.000 description 2
- XMHYMHPTGGOGBD-UHFFFAOYSA-N C(C)OC1=CC=C(CN2CC(N(C(C2)=O)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=C1 Chemical compound C(C)OC1=CC=C(CN2CC(N(C(C2)=O)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=C1 XMHYMHPTGGOGBD-UHFFFAOYSA-N 0.000 description 2
- DFCDLYFRQWOTGO-UHFFFAOYSA-N C1(CC1)C1=C(C=CC=C1)C1CN(CCN1)CC1=CC=C(C=C1)OC Chemical compound C1(CC1)C1=C(C=CC=C1)C1CN(CCN1)CC1=CC=C(C=C1)OC DFCDLYFRQWOTGO-UHFFFAOYSA-N 0.000 description 2
- REPPQXJITOHASU-UHFFFAOYSA-N C1(CC1)C1=C(C=CC=C1)C1NCCC(C1)N(C)CC1=CC=C(C=C1)OC Chemical compound C1(CC1)C1=C(C=CC=C1)C1NCCC(C1)N(C)CC1=CC=C(C=C1)OC REPPQXJITOHASU-UHFFFAOYSA-N 0.000 description 2
- KONPUFRVBSZMLD-UHFFFAOYSA-N C1(CC1)N1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound C1(CC1)N1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C KONPUFRVBSZMLD-UHFFFAOYSA-N 0.000 description 2
- BTFQHXCMSZRIJR-UHFFFAOYSA-N C1(CCC1)N1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound C1(CCC1)N1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C BTFQHXCMSZRIJR-UHFFFAOYSA-N 0.000 description 2
- XNZMEFAAMOZZEB-UHFFFAOYSA-N C1(CCCC1)C1=C(C=CC=C1)C1CN(CCN1)CC1=CC=C(C=C1)OC Chemical compound C1(CCCC1)C1=C(C=CC=C1)C1CN(CCN1)CC1=CC=C(C=C1)OC XNZMEFAAMOZZEB-UHFFFAOYSA-N 0.000 description 2
- QGJACOWDNAEGOQ-UHFFFAOYSA-N C1(CCCCC1)CN1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound C1(CCCCC1)CN1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C QGJACOWDNAEGOQ-UHFFFAOYSA-N 0.000 description 2
- ZOTNLACKYLHVGX-UHFFFAOYSA-N C1(CCCCC1)N1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound C1(CCCCC1)N1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C ZOTNLACKYLHVGX-UHFFFAOYSA-N 0.000 description 2
- QZYQNTSVIMDACA-UHFFFAOYSA-N COC1=C(CN2CC(N(C(C2)=O)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=CC(=C1)OC Chemical compound COC1=C(CN2CC(N(C(C2)=O)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=CC(=C1)OC QZYQNTSVIMDACA-UHFFFAOYSA-N 0.000 description 2
- POKYVBAINUZYBU-UHFFFAOYSA-N COC1=C(CN2CC(N(C(C2)=O)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=CC=C1OC Chemical compound COC1=C(CN2CC(N(C(C2)=O)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=CC=C1OC POKYVBAINUZYBU-UHFFFAOYSA-N 0.000 description 2
- OHNNXKUHBDFDEF-UHFFFAOYSA-N COC1=CC=C(CN2CC(NCC2)C2=C(C=CC=C2)C)C=C1 Chemical compound COC1=CC=C(CN2CC(NCC2)C2=C(C=CC=C2)C)C=C1 OHNNXKUHBDFDEF-UHFFFAOYSA-N 0.000 description 2
- MKPOQYOYYFGILJ-UHFFFAOYSA-N COC1=CC=C(CN2CCN=C(C2)C2=C(C=CC=C2)C)C=C1 Chemical compound COC1=CC=C(CN2CCN=C(C2)C2=C(C=CC=C2)C)C=C1 MKPOQYOYYFGILJ-UHFFFAOYSA-N 0.000 description 2
- DXWZJZZHPQPDCZ-UHFFFAOYSA-N COC=1C=C(CN2CC(N(C(C2)=O)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=C(C=1)OC Chemical compound COC=1C=C(CN2CC(N(C(C2)=O)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=C(C=1)OC DXWZJZZHPQPDCZ-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- NVRYKOYORKGKEO-UHFFFAOYSA-N ClC1=CC=C(CN2CC(N(C(C2)=O)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=C1 Chemical compound ClC1=CC=C(CN2CC(N(C(C2)=O)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=C1 NVRYKOYORKGKEO-UHFFFAOYSA-N 0.000 description 2
- HSZUPVUNHPGLFG-UHFFFAOYSA-N ClC1=CC=C(CN2CC(N(CC2)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=C1 Chemical compound ClC1=CC=C(CN2CC(N(CC2)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=C1 HSZUPVUNHPGLFG-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N DMSO Substances CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 244000166102 Eucalyptus leucoxylon Species 0.000 description 2
- 235000004694 Eucalyptus leucoxylon Nutrition 0.000 description 2
- RKNXWYUKYOXNCA-UHFFFAOYSA-N FC1=C(CN2CC(N(C(C2)=O)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=CC(=C1)F Chemical compound FC1=C(CN2CC(N(C(C2)=O)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=CC(=C1)F RKNXWYUKYOXNCA-UHFFFAOYSA-N 0.000 description 2
- QAPJFFPXVOGTDT-UHFFFAOYSA-N FC1=C(CN2CC(N(C(C2)=O)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=CC=C1 Chemical compound FC1=C(CN2CC(N(C(C2)=O)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=CC=C1 QAPJFFPXVOGTDT-UHFFFAOYSA-N 0.000 description 2
- LINVPBZMQFTFTP-UHFFFAOYSA-N FC1=C(CN2CC(N(CC2)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=CC(=C1)F Chemical compound FC1=C(CN2CC(N(CC2)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=CC(=C1)F LINVPBZMQFTFTP-UHFFFAOYSA-N 0.000 description 2
- HBLIKZVGGDETGV-UHFFFAOYSA-N FC1=CC=C(CN2CC(N(C(C2)=O)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=C1 Chemical compound FC1=CC=C(CN2CC(N(C(C2)=O)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=C1 HBLIKZVGGDETGV-UHFFFAOYSA-N 0.000 description 2
- VLNDKFORKPUWAB-UHFFFAOYSA-N FC=1C=C(CN2CC(N(C(C2)=O)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=C(C=1)F Chemical compound FC=1C=C(CN2CC(N(C(C2)=O)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=C(C=1)F VLNDKFORKPUWAB-UHFFFAOYSA-N 0.000 description 2
- MZNRNHAPFHGAIK-UHFFFAOYSA-N FC=1C=C(CN2CC(N(C(C2)=O)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=CC=1F Chemical compound FC=1C=C(CN2CC(N(C(C2)=O)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=CC=1F MZNRNHAPFHGAIK-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 229910010082 LiAlH Inorganic materials 0.000 description 2
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 2
- TUYUUJKTKLAELT-UHFFFAOYSA-N NC(CNS(=O)(=O)C1=CC=C(C=C1)C)C1=C(C=CC=C1)C(C)C Chemical compound NC(CNS(=O)(=O)C1=CC=C(C=C1)C)C1=C(C=CC=C1)C(C)C TUYUUJKTKLAELT-UHFFFAOYSA-N 0.000 description 2
- UIYFIHRXNGRUQA-UHFFFAOYSA-N NCC(C1=C(C=CC=C1)C(C)C)NS(=O)C(C)(C)C Chemical compound NCC(C1=C(C=CC=C1)C(C)C)NS(=O)C(C)(C)C UIYFIHRXNGRUQA-UHFFFAOYSA-N 0.000 description 2
- 239000007832 Na2SO4 Substances 0.000 description 2
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 2
- DLFOIRCIXHPFCW-UHFFFAOYSA-N O1CCC(C2=CC=CC=C12)C(=O)N1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound O1CCC(C2=CC=CC=C12)C(=O)N1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C DLFOIRCIXHPFCW-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- XYJUPNZFCHPFDE-UHFFFAOYSA-N S1C2=C(C=C1)C(=CC=C2)CN1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound S1C2=C(C=C1)C(=CC=C2)CN1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C XYJUPNZFCHPFDE-UHFFFAOYSA-N 0.000 description 2
- 229940124639 Selective inhibitor Drugs 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- CSCPPACGZOOCGX-WFGJKAKNSA-N acetone d6 Chemical compound [2H]C([2H])([2H])C(=O)C([2H])([2H])[2H] CSCPPACGZOOCGX-WFGJKAKNSA-N 0.000 description 2
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 125000004273 azetidin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])C1([H])* 0.000 description 2
- 125000004567 azetidin-3-yl group Chemical group N1CC(C1)* 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 2
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 2
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 2
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 239000003560 cancer drug Substances 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
- NXQGGXCHGDYOHB-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 description 2
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 2
- WLVKDFJTYKELLQ-UHFFFAOYSA-N cyclopropylboronic acid Chemical compound OB(O)C1CC1 WLVKDFJTYKELLQ-UHFFFAOYSA-N 0.000 description 2
- NNBZCPXTIHJBJL-UHFFFAOYSA-N decalin Chemical compound C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 229910052805 deuterium Inorganic materials 0.000 description 2
- 239000000032 diagnostic agent Substances 0.000 description 2
- 229940039227 diagnostic agent Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- MFGTVBWCUZVUJN-UHFFFAOYSA-N ethyl 1-cyclopropylpyrazole-4-carboxylate Chemical compound C1(CC1)N1N=CC(=C1)C(=O)OCC MFGTVBWCUZVUJN-UHFFFAOYSA-N 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 238000001640 fractional crystallisation Methods 0.000 description 2
- 125000001188 haloalkyl group Chemical group 0.000 description 2
- 125000000592 heterocycloalkyl group Chemical group 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 2
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 239000012669 liquid formulation Substances 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 239000001095 magnesium carbonate Substances 0.000 description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 2
- 235000014380 magnesium carbonate Nutrition 0.000 description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
- AYIKWNUPJNWKMX-UHFFFAOYSA-N methyl 3-methoxy-1-methylpyrazole-4-carboxylate Chemical compound COC(=O)C1=CN(C)N=C1OC AYIKWNUPJNWKMX-UHFFFAOYSA-N 0.000 description 2
- GAWWMETUNCXVML-UHFFFAOYSA-N methyl 3-oxo-1,2-dihydropyrazole-4-carboxylate Chemical compound COC(=O)C1=CNNC1=O GAWWMETUNCXVML-UHFFFAOYSA-N 0.000 description 2
- 125000004572 morpholin-3-yl group Chemical group N1C(COCC1)* 0.000 description 2
- 125000002757 morpholinyl group Chemical group 0.000 description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 208000015122 neurodegenerative disease Diseases 0.000 description 2
- 239000012053 oil suspension Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- FXLOVSHXALFLKQ-UHFFFAOYSA-N p-tolualdehyde Chemical compound CC1=CC=C(C=O)C=C1 FXLOVSHXALFLKQ-UHFFFAOYSA-N 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 2
- DTUQWGWMVIHBKE-UHFFFAOYSA-N phenylacetaldehyde Chemical compound O=CCC1=CC=CC=C1 DTUQWGWMVIHBKE-UHFFFAOYSA-N 0.000 description 2
- IWELDVXSEVIIGI-UHFFFAOYSA-N piperazin-2-one Chemical compound O=C1CNCCN1 IWELDVXSEVIIGI-UHFFFAOYSA-N 0.000 description 2
- 125000004574 piperidin-2-yl group Chemical group N1C(CCCC1)* 0.000 description 2
- 125000004483 piperidin-3-yl group Chemical group N1CC(CCC1)* 0.000 description 2
- BCIIMDOZSUCSEN-UHFFFAOYSA-N piperidin-4-amine Chemical compound NC1CCNCC1 BCIIMDOZSUCSEN-UHFFFAOYSA-N 0.000 description 2
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 125000003373 pyrazinyl group Chemical group 0.000 description 2
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 2
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 125000003003 spiro group Chemical group 0.000 description 2
- WFZPZHXVHKEVAZ-UHFFFAOYSA-N spiro[1,3-dihydroindene-2,2'-pyrrolidine] Chemical compound C1CCNC21CC1=CC=CC=C1C2 WFZPZHXVHKEVAZ-UHFFFAOYSA-N 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Substances C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 2
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- 125000002053 thietanyl group Chemical group 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- BZMMRNKDONDVIB-UHFFFAOYSA-N (1-ethoxycyclopropyl)oxy-trimethylsilane Chemical compound CCOC1(O[Si](C)(C)C)CC1 BZMMRNKDONDVIB-UHFFFAOYSA-N 0.000 description 1
- PAORVUMOXXAMPL-SECBINFHSA-N (2s)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoyl chloride Chemical compound CO[C@](C(Cl)=O)(C(F)(F)F)C1=CC=CC=C1 PAORVUMOXXAMPL-SECBINFHSA-N 0.000 description 1
- NQMRYYAAICMHPE-UHFFFAOYSA-N (4-methoxyphenyl)boron Chemical compound [B]C1=CC=C(OC)C=C1 NQMRYYAAICMHPE-UHFFFAOYSA-N 0.000 description 1
- FDGCNGPUZIIRQI-UHFFFAOYSA-N (4-methoxyphenyl)methanone Chemical compound O(C1=CC=C([C-]=O)C=C1)C FDGCNGPUZIIRQI-UHFFFAOYSA-N 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 description 1
- 125000005988 1,1-dioxo-thiomorpholinyl group Chemical group 0.000 description 1
- 125000004502 1,2,3-oxadiazolyl group Chemical group 0.000 description 1
- 125000004511 1,2,3-thiadiazolyl group Chemical group 0.000 description 1
- 125000001399 1,2,3-triazolyl group Chemical group N1N=NC(=C1)* 0.000 description 1
- 125000004504 1,2,4-oxadiazolyl group Chemical group 0.000 description 1
- 125000004514 1,2,4-thiadiazolyl group Chemical group 0.000 description 1
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 description 1
- MUZIZEZCKKMZRT-UHFFFAOYSA-N 1,2-dithiolane Chemical group C1CSSC1 MUZIZEZCKKMZRT-UHFFFAOYSA-N 0.000 description 1
- 125000001781 1,3,4-oxadiazolyl group Chemical group 0.000 description 1
- 125000004520 1,3,4-thiadiazolyl group Chemical group 0.000 description 1
- JBWIIXBEPINWPB-UHFFFAOYSA-N 1,3-oxazole-4-carbaldehyde Chemical compound O=CC1=COC=N1 JBWIIXBEPINWPB-UHFFFAOYSA-N 0.000 description 1
- 125000005940 1,4-dioxanyl group Chemical group 0.000 description 1
- KLXZPUSMSLXPAY-UHFFFAOYSA-N 1,4-dioxine-2-carbaldehyde Chemical compound O=CC1=COC=CO1 KLXZPUSMSLXPAY-UHFFFAOYSA-N 0.000 description 1
- 125000005962 1,4-oxazepanyl group Chemical group 0.000 description 1
- SGUVLZREKBPKCE-UHFFFAOYSA-N 1,5-diazabicyclo[4.3.0]-non-5-ene Chemical compound C1CCN=C2CCCN21 SGUVLZREKBPKCE-UHFFFAOYSA-N 0.000 description 1
- AIJFPNKGGAPZFJ-UHFFFAOYSA-N 1-(4-methoxyphenyl)-n-methylmethanamine Chemical compound CNCC1=CC=C(OC)C=C1 AIJFPNKGGAPZFJ-UHFFFAOYSA-N 0.000 description 1
- CCSZLLVNXGKALH-UHFFFAOYSA-N 1-benzothiophen-4-ylmethanol Chemical compound OCC1=CC=CC2=C1C=CS2 CCSZLLVNXGKALH-UHFFFAOYSA-N 0.000 description 1
- WTCQKBKVLYOTFC-UHFFFAOYSA-N 1-benzothiophene-4-carbaldehyde Chemical compound O=CC1=CC=CC2=C1C=CS2 WTCQKBKVLYOTFC-UHFFFAOYSA-N 0.000 description 1
- QHHRWAPVYHRAJA-UHFFFAOYSA-N 1-benzothiophene-5-carbaldehyde Chemical compound O=CC1=CC=C2SC=CC2=C1 QHHRWAPVYHRAJA-UHFFFAOYSA-N 0.000 description 1
- YZUPZGFPHUVJKC-UHFFFAOYSA-N 1-bromo-2-methoxyethane Chemical compound COCCBr YZUPZGFPHUVJKC-UHFFFAOYSA-N 0.000 description 1
- QSSXJPIWXQTSIX-UHFFFAOYSA-N 1-bromo-2-methylbenzene Chemical compound CC1=CC=CC=C1Br QSSXJPIWXQTSIX-UHFFFAOYSA-N 0.000 description 1
- CRRUGYDDEMGVDY-UHFFFAOYSA-N 1-bromoethylbenzene Chemical compound CC(Br)C1=CC=CC=C1 CRRUGYDDEMGVDY-UHFFFAOYSA-N 0.000 description 1
- BTUGGGLMQBJCBN-UHFFFAOYSA-N 1-iodo-2-methylpropane Chemical compound CC(C)CI BTUGGGLMQBJCBN-UHFFFAOYSA-N 0.000 description 1
- LLSKXGRDUPMXLC-UHFFFAOYSA-N 1-phenylpiperidine Chemical group C1CCCCN1C1=CC=CC=C1 LLSKXGRDUPMXLC-UHFFFAOYSA-N 0.000 description 1
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- XHLHPRDBBAGVEG-UHFFFAOYSA-N 1-tetralone Chemical compound C1=CC=C2C(=O)CCCC2=C1 XHLHPRDBBAGVEG-UHFFFAOYSA-N 0.000 description 1
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 1
- 125000001617 2,3-dimethoxy phenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C(OC([H])([H])[H])=C1[H] 0.000 description 1
- WCGPCBACLBHDCI-UHFFFAOYSA-N 2,4-difluorobenzaldehyde Chemical compound FC1=CC=C(C=O)C(F)=C1 WCGPCBACLBHDCI-UHFFFAOYSA-N 0.000 description 1
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 description 1
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 1
- BKWXAXRCUCTBTK-UHFFFAOYSA-N 2-(2-propan-2-ylphenyl)piperazine Chemical compound CC(C)C1=CC=CC=C1C1NCCNC1 BKWXAXRCUCTBTK-UHFFFAOYSA-N 0.000 description 1
- NRIVMXXOUOBRAG-UHFFFAOYSA-N 2-(4-methoxyphenyl)acetaldehyde Chemical compound COC1=CC=C(CC=O)C=C1 NRIVMXXOUOBRAG-UHFFFAOYSA-N 0.000 description 1
- DKGWBAJILKCXCQ-UHFFFAOYSA-N 2-[2-(2-propan-2-ylphenyl)-4-(pyridin-2-ylmethyl)piperazin-1-yl]-7-azaspiro[3.5]nonane Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=NC=CC=C1)C1CC2(C1)CCNCC2 DKGWBAJILKCXCQ-UHFFFAOYSA-N 0.000 description 1
- IBODJKKYTBNWTD-UHFFFAOYSA-N 2-azaspiro[3.5]nonane Chemical compound C1NCC11CCCCC1 IBODJKKYTBNWTD-UHFFFAOYSA-N 0.000 description 1
- ZWDVQMVZZYIAHO-UHFFFAOYSA-N 2-fluorobenzaldehyde Chemical compound FC1=CC=CC=C1C=O ZWDVQMVZZYIAHO-UHFFFAOYSA-N 0.000 description 1
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 1
- 125000004398 2-methyl-2-butyl group Chemical group CC(C)(CC)* 0.000 description 1
- 125000004918 2-methyl-2-pentyl group Chemical group CC(C)(CCC)* 0.000 description 1
- FMUCJSFAXFPZHB-UHFFFAOYSA-N 2-methyl-5-oxo-1h-pyrazole-4-carboxylic acid Chemical compound CN1C=C(C(O)=O)C(=O)N1 FMUCJSFAXFPZHB-UHFFFAOYSA-N 0.000 description 1
- 239000001431 2-methylbenzaldehyde Substances 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- CESUXLKAADQNTB-SSDOTTSWSA-N 2-methylpropane-2-sulfinamide Chemical compound CC(C)(C)[S@](N)=O CESUXLKAADQNTB-SSDOTTSWSA-N 0.000 description 1
- ZHAIMJRKJKQNQI-UHFFFAOYSA-N 2-oxa-7-azaspiro[3.4]octane Chemical compound C1OCC11CNCC1 ZHAIMJRKJKQNQI-UHFFFAOYSA-N 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000004485 2-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 description 1
- 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- LGCYVLDNGBSOOW-UHFFFAOYSA-N 2H-benzotriazol-4-ol 1-hydroxybenzotriazole Chemical compound OC1=CC=CC2=C1N=NN2.C1=CC=C2N(O)N=NC2=C1 LGCYVLDNGBSOOW-UHFFFAOYSA-N 0.000 description 1
- 125000001698 2H-pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 125000005809 3,4,5-trimethoxyphenyl group Chemical group [H]C1=C(OC([H])([H])[H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 1
- YIHDTNNFJDJYRG-UHFFFAOYSA-N 3,4-dihydro-2h-chromene-6-carbaldehyde Chemical compound O1CCCC2=CC(C=O)=CC=C21 YIHDTNNFJDJYRG-UHFFFAOYSA-N 0.000 description 1
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 1
- ASOFZHSTJHGQDT-UHFFFAOYSA-N 3,5-difluorobenzaldehyde Chemical compound FC1=CC(F)=CC(C=O)=C1 ASOFZHSTJHGQDT-UHFFFAOYSA-N 0.000 description 1
- 125000004211 3,5-difluorophenyl group Chemical group [H]C1=C(F)C([H])=C(*)C([H])=C1F 0.000 description 1
- QIOCQCYXBYUYLH-YACUFSJGSA-N 3-[1-[(3r)-3-[4-[[4-[4-[3-[2-(4-chlorophenyl)-5-methyl-4-methylsulfonyl-1-propan-2-ylpyrrol-3-yl]-5-fluorophenyl]piperazin-1-yl]phenyl]sulfamoyl]-2-(trifluoromethylsulfonyl)anilino]-4-phenylsulfanylbutyl]piperidine-4-carbonyl]oxypropylphosphonic acid Chemical compound CC(C)N1C(C)=C(S(C)(=O)=O)C(C=2C=C(C=C(F)C=2)N2CCN(CC2)C=2C=CC(NS(=O)(=O)C=3C=C(C(N[C@H](CCN4CCC(CC4)C(=O)OCCCP(O)(O)=O)CSC=4C=CC=CC=4)=CC=3)S(=O)(=O)C(F)(F)F)=CC=2)=C1C1=CC=C(Cl)C=C1 QIOCQCYXBYUYLH-YACUFSJGSA-N 0.000 description 1
- HVAHFQXXFIFIOJ-UHFFFAOYSA-N 3-fluoro-5-methoxy-1H-pyrrolo[2,3-b]pyridine Chemical compound COc1cnc2[nH]cc(F)c2c1 HVAHFQXXFIFIOJ-UHFFFAOYSA-N 0.000 description 1
- PIKNVEVCWAAOMJ-UHFFFAOYSA-N 3-fluorobenzaldehyde Chemical compound FC1=CC=CC(C=O)=C1 PIKNVEVCWAAOMJ-UHFFFAOYSA-N 0.000 description 1
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 1
- AZVSIHIBYRHSLB-UHFFFAOYSA-N 3-furaldehyde Chemical compound O=CC=1C=COC=1 AZVSIHIBYRHSLB-UHFFFAOYSA-N 0.000 description 1
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 1
- 125000004919 3-methyl-2-pentyl group Chemical group CC(C(C)*)CC 0.000 description 1
- 125000004921 3-methyl-3-pentyl group Chemical group CC(CC)(CC)* 0.000 description 1
- ROADCYAOHVSOLQ-UHFFFAOYSA-N 3-oxetanone Chemical compound O=C1COC1 ROADCYAOHVSOLQ-UHFFFAOYSA-N 0.000 description 1
- GRFNBEZIAWKNCO-UHFFFAOYSA-N 3-pyridinol Chemical compound OC1=CC=CN=C1 GRFNBEZIAWKNCO-UHFFFAOYSA-N 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000004364 3-pyrrolinyl group Chemical group [H]C1=C([H])C([H])([H])N(*)C1([H])[H] 0.000 description 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- SLJYPZJZQIHNGU-UHFFFAOYSA-N 4-(4-hydroxyphenyl)cyclohexan-1-one Chemical compound C1=CC(O)=CC=C1C1CCC(=O)CC1 SLJYPZJZQIHNGU-UHFFFAOYSA-N 0.000 description 1
- XQNVDQZWOBPLQZ-UHFFFAOYSA-N 4-(trifluoromethoxy)benzaldehyde Chemical compound FC(F)(F)OC1=CC=C(C=O)C=C1 XQNVDQZWOBPLQZ-UHFFFAOYSA-N 0.000 description 1
- BEOBZEOPTQQELP-UHFFFAOYSA-N 4-(trifluoromethyl)benzaldehyde Chemical compound FC(F)(F)C1=CC=C(C=O)C=C1 BEOBZEOPTQQELP-UHFFFAOYSA-N 0.000 description 1
- MSTDXOZUKAQDRL-UHFFFAOYSA-N 4-Chromanone Chemical compound C1=CC=C2C(=O)CCOC2=C1 MSTDXOZUKAQDRL-UHFFFAOYSA-N 0.000 description 1
- WZWIQYMTQZCSKI-UHFFFAOYSA-N 4-cyanobenzaldehyde Chemical compound O=CC1=CC=C(C#N)C=C1 WZWIQYMTQZCSKI-UHFFFAOYSA-N 0.000 description 1
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- JRHHJNMASOIRDS-UHFFFAOYSA-N 4-ethoxybenzaldehyde Chemical compound CCOC1=CC=C(C=O)C=C1 JRHHJNMASOIRDS-UHFFFAOYSA-N 0.000 description 1
- 125000004920 4-methyl-2-pentyl group Chemical group CC(CC(C)*)C 0.000 description 1
- 125000001826 4H-pyranyl group Chemical group O1C(=CCC=C1)* 0.000 description 1
- 125000001054 5 membered carbocyclic group Chemical group 0.000 description 1
- HTMGQIXFZMZZKD-UHFFFAOYSA-N 5,6,7,8-tetrahydroisoquinoline Chemical compound N1=CC=C2CCCCC2=C1 HTMGQIXFZMZZKD-UHFFFAOYSA-N 0.000 description 1
- FEEYLWOKLCNDQR-UHFFFAOYSA-N 5-bromo-3-fluoro-1h-pyrrolo[2,3-b]pyridine Chemical compound C1=C(Br)C=C2C(F)=CNC2=N1 FEEYLWOKLCNDQR-UHFFFAOYSA-N 0.000 description 1
- 125000004008 6 membered carbocyclic group Chemical group 0.000 description 1
- CTAIEPPAOULMFY-UHFFFAOYSA-N 6-methoxypyridine-3-carbaldehyde Chemical compound COC1=CC=C(C=O)C=N1 CTAIEPPAOULMFY-UHFFFAOYSA-N 0.000 description 1
- BSQKGAVROUDOTE-UHFFFAOYSA-N 7-azaspiro[3.5]nonane Chemical compound C1CCC21CCNCC2 BSQKGAVROUDOTE-UHFFFAOYSA-N 0.000 description 1
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 1
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- ZRSNZINYAWTAHE-UHFFFAOYSA-N Anisaldehyde Natural products COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 1
- 102000010565 Apoptosis Regulatory Proteins Human genes 0.000 description 1
- 108010063104 Apoptosis Regulatory Proteins Proteins 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 208000003950 B-cell lymphoma Diseases 0.000 description 1
- FRYRJNHMRVINIZ-UHFFFAOYSA-N B1CCOO1 Chemical compound B1CCOO1 FRYRJNHMRVINIZ-UHFFFAOYSA-N 0.000 description 1
- 229940122035 Bcl-XL inhibitor Drugs 0.000 description 1
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- AOFXLXZNGCXHDQ-UHFFFAOYSA-N C(#N)C1=CC=C(CN2CC(N(CC2)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=C1 Chemical compound C(#N)C1=CC=C(CN2CC(N(CC2)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=C1 AOFXLXZNGCXHDQ-UHFFFAOYSA-N 0.000 description 1
- WLIAAYHFOKJJSM-UHFFFAOYSA-N C(C(C)C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=CC=C(C=C1)OC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C(C)C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=CC=C(C=C1)OC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C WLIAAYHFOKJJSM-UHFFFAOYSA-N 0.000 description 1
- VSSMGMOEYZIBMY-UHFFFAOYSA-N C(C(C)C)N1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound C(C(C)C)N1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C VSSMGMOEYZIBMY-UHFFFAOYSA-N 0.000 description 1
- NQIQKNJWDZZJDL-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)C(=O)C12CC(C1)(C2)C(=O)OC)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)C(=O)C12CC(C1)(C2)C(=O)OC)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C NQIQKNJWDZZJDL-UHFFFAOYSA-N 0.000 description 1
- GDEFCUVYMVBWDR-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)C1CCOCC1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)C1CCOCC1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C GDEFCUVYMVBWDR-UHFFFAOYSA-N 0.000 description 1
- BHKRYBBLAQPKEW-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)C1COCC1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)C1COCC1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C BHKRYBBLAQPKEW-UHFFFAOYSA-N 0.000 description 1
- MRNLADJKWLPOIW-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)CC1=CC=2CCCCC=2C=C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)CC1=CC=2CCCCC=2C=C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C MRNLADJKWLPOIW-UHFFFAOYSA-N 0.000 description 1
- FVXDPDBJSJKACM-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)CC1=CC=CC=2CCCCC1=2)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)CC1=CC=CC=2CCCCC1=2)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C FVXDPDBJSJKACM-UHFFFAOYSA-N 0.000 description 1
- SGRJUPIAAZBHHL-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)CC1CCOCC1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)CC1CCOCC1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C SGRJUPIAAZBHHL-UHFFFAOYSA-N 0.000 description 1
- AVEMLFCVYLPNAF-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)CC=1C(=NN(C=1)C)OC)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)CC=1C(=NN(C=1)C)OC)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C AVEMLFCVYLPNAF-UHFFFAOYSA-N 0.000 description 1
- WZBPQOBIFLSSSZ-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)CC=1C=NC(=CC=1)OC)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)CC=1C=NC(=CC=1)OC)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C WZBPQOBIFLSSSZ-UHFFFAOYSA-N 0.000 description 1
- PEAMJWUMFBKHFU-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)CC=1C=NN(C=1)C)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)CC=1C=NN(C=1)C)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C PEAMJWUMFBKHFU-UHFFFAOYSA-N 0.000 description 1
- SDWUMJJADFNQQB-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)CCC1=CC=CC=C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)CCC1=CC=CC=C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C SDWUMJJADFNQQB-UHFFFAOYSA-N 0.000 description 1
- WHVXARWGORTYSS-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)S(=O)(=O)C1=CC=C(C)C=C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(C(CN(C1)S(=O)(=O)C1=CC=C(C)C=C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C WHVXARWGORTYSS-UHFFFAOYSA-N 0.000 description 1
- USHMAIAEHRWTIY-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CC(N(C1)CC1=CC=C(C=C1)OC)C)C1CC2(C1)CCNCC2 Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CC(N(C1)CC1=CC=C(C=C1)OC)C)C1CC2(C1)CCNCC2 USHMAIAEHRWTIY-UHFFFAOYSA-N 0.000 description 1
- JONSWNRWOHDLOK-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCC(C1)OC1=CC=CC=C1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCC(C1)OC1=CC=CC=C1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C JONSWNRWOHDLOK-UHFFFAOYSA-N 0.000 description 1
- CFGDYFMRWFUPFI-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)C(C#CC)C1=CC=CC=C1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)C(C#CC)C1=CC=CC=C1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C CFGDYFMRWFUPFI-UHFFFAOYSA-N 0.000 description 1
- CQXQULLJUFVONO-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)C(C)C1=CC=CC=C1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)C(C)C1=CC=CC=C1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C CQXQULLJUFVONO-UHFFFAOYSA-N 0.000 description 1
- YRNXHFXWDQZYAN-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)C(C1=CC=C(C=C1)OC)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)C(C1=CC=C(C=C1)OC)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C YRNXHFXWDQZYAN-UHFFFAOYSA-N 0.000 description 1
- HTLJEKFJGBTZFU-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)C1CC(CC1)C1=CC=CC=C1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)C1CC(CC1)C1=CC=CC=C1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C HTLJEKFJGBTZFU-UHFFFAOYSA-N 0.000 description 1
- PLVNEEPVQWIBHB-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)C1CCC(CC1)C1=CC=C(C=C1)OC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)C1CCC(CC1)C1=CC=C(C=C1)OC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C PLVNEEPVQWIBHB-UHFFFAOYSA-N 0.000 description 1
- ZKDWOZWRIFSBPM-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)C1CCCC2=CC=CC=C12)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)C1CCCC2=CC=CC=C12)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C ZKDWOZWRIFSBPM-UHFFFAOYSA-N 0.000 description 1
- QVUZEYVUEDFTSZ-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)C1CCOCC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)C1CCOCC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C QVUZEYVUEDFTSZ-UHFFFAOYSA-N 0.000 description 1
- AOYXVFKBOWIYOP-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)C1COC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)C1COC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C AOYXVFKBOWIYOP-UHFFFAOYSA-N 0.000 description 1
- QWQUSQWRBMHJMQ-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)C1COC1)C1CC2(C1)CCNCC2 Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)C1COC1)C1CC2(C1)CCNCC2 QWQUSQWRBMHJMQ-UHFFFAOYSA-N 0.000 description 1
- WSINVINNQSECTR-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)C1COCC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)C1COCC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C WSINVINNQSECTR-UHFFFAOYSA-N 0.000 description 1
- FWWRFPMWGRAKFF-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC(C)(C)C)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC(C)(C)C)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C FWWRFPMWGRAKFF-UHFFFAOYSA-N 0.000 description 1
- NUQIICOZMPPHPI-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=C(C=CC=C1)OC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=C(C=CC=C1)OC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C NUQIICOZMPPHPI-UHFFFAOYSA-N 0.000 description 1
- GZCRLMOMAASEMO-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=CC(=C(C(=C1)OC)OC)OC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=CC(=C(C(=C1)OC)OC)OC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C GZCRLMOMAASEMO-UHFFFAOYSA-N 0.000 description 1
- QVRLTSAQQBEZNN-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=CC(=CC=C1)OC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=CC(=CC=C1)OC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C QVRLTSAQQBEZNN-UHFFFAOYSA-N 0.000 description 1
- NVXWPHNFZPWCLM-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=CC=2CCCCC=2C=C1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=CC=2CCCCC=2C=C1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C NVXWPHNFZPWCLM-UHFFFAOYSA-N 0.000 description 1
- YKAMVBCJTQFFTF-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=CC=C(C=C1)C(F)(F)F)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=CC=C(C=C1)C(F)(F)F)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C YKAMVBCJTQFFTF-UHFFFAOYSA-N 0.000 description 1
- UPLVVOWPRYLVKU-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=CC=C(C=C1)C)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=CC=C(C=C1)C)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C UPLVVOWPRYLVKU-UHFFFAOYSA-N 0.000 description 1
- QZXPPHPDAZLEHC-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=CC=C(C=C1)OC(F)(F)F)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=CC=C(C=C1)OC(F)(F)F)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C QZXPPHPDAZLEHC-UHFFFAOYSA-N 0.000 description 1
- FOECTYRNHIWXFJ-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=CC=C(C=C1)OC)C1CC2(CNC2)C1 Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=CC=C(C=C1)OC)C1CC2(CNC2)C1 FOECTYRNHIWXFJ-UHFFFAOYSA-N 0.000 description 1
- VTKUZZIFGXVLOB-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=CC=C(C=C1)S(=O)(=O)C)C1CC2(C1)CCNCC2 Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=CC=C(C=C1)S(=O)(=O)C)C1CC2(C1)CCNCC2 VTKUZZIFGXVLOB-UHFFFAOYSA-N 0.000 description 1
- MMBFCAWOVHHYFR-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=CC=CC=2CCCCC1=2)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=CC=CC=2CCCCC1=2)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C MMBFCAWOVHHYFR-UHFFFAOYSA-N 0.000 description 1
- CBQCSDXEXUSTTN-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=NC=C(N=C1)OC)C1CC2(C1)CCNCC2 Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=NC=C(N=C1)OC)C1CC2(C1)CCNCC2 CBQCSDXEXUSTTN-UHFFFAOYSA-N 0.000 description 1
- RXUYEICESCAWAS-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1CCC(CC1)OC)C1CC2(C1)CCNCC2 Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1CCC(CC1)OC)C1CC2(C1)CCNCC2 RXUYEICESCAWAS-UHFFFAOYSA-N 0.000 description 1
- XULCWFPLAKZXNE-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1CCOCC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1CCOCC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C XULCWFPLAKZXNE-UHFFFAOYSA-N 0.000 description 1
- FHQZKXGXDMXKDX-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC=1C(=NN(C=1)C)OC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC=1C(=NN(C=1)C)OC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C FHQZKXGXDMXKDX-UHFFFAOYSA-N 0.000 description 1
- BGWQZSHZQIPRDN-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC=1C=NC(=CC=1)OC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC=1C=NC(=CC=1)OC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C BGWQZSHZQIPRDN-UHFFFAOYSA-N 0.000 description 1
- VRDVLVIAZUBOCC-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC=1C=NC=CC=1)C1CC2(C1)CCNCC2 Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC=1C=NC=CC=1)C1CC2(C1)CCNCC2 VRDVLVIAZUBOCC-UHFFFAOYSA-N 0.000 description 1
- IDBFYGUHZGGKBX-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC=1C=NN(C=1)C)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC=1C=NN(C=1)C)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C IDBFYGUHZGGKBX-UHFFFAOYSA-N 0.000 description 1
- JTQCIQNUEGCAIM-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC=1N=COC=1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CC=1N=COC=1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C JTQCIQNUEGCAIM-UHFFFAOYSA-N 0.000 description 1
- MIWSNPLMUPCWOZ-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CCC1=CC=C(C=C1)OC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CCC1=CC=C(C=C1)OC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C MIWSNPLMUPCWOZ-UHFFFAOYSA-N 0.000 description 1
- LIIHVLLNDKBWBW-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CCC1=CC=C(C=C1)OC)C1CC2(CNC2)C1 Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CCC1=CC=C(C=C1)OC)C1CC2(CNC2)C1 LIIHVLLNDKBWBW-UHFFFAOYSA-N 0.000 description 1
- GUHFZVXXVCGRAO-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CCC1=CC=CC=C1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CCC1=CC=CC=C1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C GUHFZVXXVCGRAO-UHFFFAOYSA-N 0.000 description 1
- KPLPUXCFYDCVSH-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CCOC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CCOC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C KPLPUXCFYDCVSH-UHFFFAOYSA-N 0.000 description 1
- WZNMQLMJLFGURG-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CCOC)C1CC2(C1)CCNCC2 Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)CCOC)C1CC2(C1)CCNCC2 WZNMQLMJLFGURG-UHFFFAOYSA-N 0.000 description 1
- JCRZKEOWXUMIJR-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)S(=O)(=O)C)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)S(=O)(=O)C)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C JCRZKEOWXUMIJR-UHFFFAOYSA-N 0.000 description 1
- XGKRVZXJQVHICC-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)S(=O)(=O)C1=CC=CC=C1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1)S(=O)(=O)C1=CC=CC=C1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C XGKRVZXJQVHICC-UHFFFAOYSA-N 0.000 description 1
- VDFVVGUUMYRUSQ-UHFFFAOYSA-N C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1C)CC1=CC=C(C=C1)OC)C1CC2(C1)CCNCC2 Chemical compound C(C)(C)C1=C(C=CC=C1)C1N(CCN(C1C)CC1=CC=C(C=C1)OC)C1CC2(C1)CCNCC2 VDFVVGUUMYRUSQ-UHFFFAOYSA-N 0.000 description 1
- GQMGZUQRUDODTF-UHFFFAOYSA-N C(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=CC=C(C=C1)OC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C(C)C1=C(C=CC=C1)C1N(CCN(C1)CC1=CC=C(C=C1)OC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C GQMGZUQRUDODTF-UHFFFAOYSA-N 0.000 description 1
- UOPQYEZWPWWTTE-UHFFFAOYSA-N C(C)N1C(C(N(CC1)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C)=O Chemical compound C(C)N1C(C(N(CC1)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C)=O UOPQYEZWPWWTTE-UHFFFAOYSA-N 0.000 description 1
- MWPIICAIPGCNSA-UHFFFAOYSA-N C(C)N1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound C(C)N1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C MWPIICAIPGCNSA-UHFFFAOYSA-N 0.000 description 1
- XYOYEXAHORJYBA-UHFFFAOYSA-N C(C)OC1=CC=C(CN2CC(N(CC2)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=C1 Chemical compound C(C)OC1=CC=C(CN2CC(N(CC2)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=C1 XYOYEXAHORJYBA-UHFFFAOYSA-N 0.000 description 1
- WCKUYNUKHZJHLJ-UHFFFAOYSA-N C(C1=CC=CC=C1)(=O)N1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound C(C1=CC=CC=C1)(=O)N1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C WCKUYNUKHZJHLJ-UHFFFAOYSA-N 0.000 description 1
- KYHWCEOPCYTCHH-UHFFFAOYSA-N C(C1=CC=CC=C1)C1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound C(C1=CC=CC=C1)C1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C KYHWCEOPCYTCHH-UHFFFAOYSA-N 0.000 description 1
- CIGVQMYHVZECBV-UHFFFAOYSA-N C(C1=CC=CC=C1)N1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound C(C1=CC=CC=C1)N1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C CIGVQMYHVZECBV-UHFFFAOYSA-N 0.000 description 1
- CAUAWPWYJMAXBE-UHFFFAOYSA-N C(C1=CC=CC=C1)N1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound C(C1=CC=CC=C1)N1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C CAUAWPWYJMAXBE-UHFFFAOYSA-N 0.000 description 1
- MRYXOUNACKVAAY-UHFFFAOYSA-N C1(CC1)C1=C(C=CC=C1)C1N(CCC(C1)N(C)CC1=CC=C(C=C1)OC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C1(CC1)C1=C(C=CC=C1)C1N(CCC(C1)N(C)CC1=CC=C(C=C1)OC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C MRYXOUNACKVAAY-UHFFFAOYSA-N 0.000 description 1
- PZPDAGKRWQEDGH-UHFFFAOYSA-N C1(CC1)C1=C(C=CC=C1)C1N(CCN(C1)CC1=CC=C(C=C1)OC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C1(CC1)C1=C(C=CC=C1)C1N(CCN(C1)CC1=CC=C(C=C1)OC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C PZPDAGKRWQEDGH-UHFFFAOYSA-N 0.000 description 1
- ZYOMRYCGYFGIFU-UHFFFAOYSA-N C1(CC1)N1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound C1(CC1)N1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C ZYOMRYCGYFGIFU-UHFFFAOYSA-N 0.000 description 1
- UPVVIKXCJGABTH-UHFFFAOYSA-N C1(CC1)N1N=C(C(=C1)C(=O)O)CC Chemical compound C1(CC1)N1N=C(C(=C1)C(=O)O)CC UPVVIKXCJGABTH-UHFFFAOYSA-N 0.000 description 1
- QQIXRZDNGKQPRP-UHFFFAOYSA-N C1(CC1)N1N=CC(=C1)CN1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound C1(CC1)N1N=CC(=C1)CN1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C QQIXRZDNGKQPRP-UHFFFAOYSA-N 0.000 description 1
- DYNGNHSXNQSZSA-UHFFFAOYSA-N C1(CC1)N1N=CC(=C1)CN1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound C1(CC1)N1N=CC(=C1)CN1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C DYNGNHSXNQSZSA-UHFFFAOYSA-N 0.000 description 1
- CPPITQXSZBOXHU-UHFFFAOYSA-N C1(CCC1)N1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound C1(CCC1)N1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C CPPITQXSZBOXHU-UHFFFAOYSA-N 0.000 description 1
- MOBGQMYXTPMCIP-UHFFFAOYSA-N C1(CCCC1)C1=C(C=CC=C1)C1N(CCN(C1)CC1=CC=C(C=C1)OC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C Chemical compound C1(CCCC1)C1=C(C=CC=C1)C1N(CCN(C1)CC1=CC=C(C=C1)OC)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C MOBGQMYXTPMCIP-UHFFFAOYSA-N 0.000 description 1
- YACACVJRWXXKEL-UHFFFAOYSA-N C1(CCCC1)CN1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound C1(CCCC1)CN1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C YACACVJRWXXKEL-UHFFFAOYSA-N 0.000 description 1
- WTZKEVXSBRBDPK-UHFFFAOYSA-N C1(CCCC1)CN1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound C1(CCCC1)CN1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C WTZKEVXSBRBDPK-UHFFFAOYSA-N 0.000 description 1
- AIWLONSQFSFXKV-UHFFFAOYSA-N C1(CCCC1)N1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound C1(CCCC1)N1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C AIWLONSQFSFXKV-UHFFFAOYSA-N 0.000 description 1
- WHJYFQHXYJVESX-UHFFFAOYSA-N C1(CCCC1)N1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound C1(CCCC1)N1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C WHJYFQHXYJVESX-UHFFFAOYSA-N 0.000 description 1
- ZSWHTAPBAVMKOH-UHFFFAOYSA-N C1(CCCCC1)CN1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound C1(CCCCC1)CN1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C ZSWHTAPBAVMKOH-UHFFFAOYSA-N 0.000 description 1
- WNZGCIRRGDPQKU-UHFFFAOYSA-N C1(CCCCC1)N1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound C1(CCCCC1)N1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C WNZGCIRRGDPQKU-UHFFFAOYSA-N 0.000 description 1
- AANWRRFIERNTLR-UHFFFAOYSA-N C12(CC(C1)C2)C(=O)N1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound C12(CC(C1)C2)C(=O)N1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C AANWRRFIERNTLR-UHFFFAOYSA-N 0.000 description 1
- TYGWMJLEGIDUHX-UHFFFAOYSA-N C12(CC(C1)C2)CN1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound C12(CC(C1)C2)CN1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C TYGWMJLEGIDUHX-UHFFFAOYSA-N 0.000 description 1
- QUHAWAZXXMNVRR-UHFFFAOYSA-N CC(C)C1=C(C(CN(CC2=CN(C)N=C2)C2)N(C(C3)CC3(CC3)CCN3C(O)=O)C2=O)C=CC=C1 Chemical compound CC(C)C1=C(C(CN(CC2=CN(C)N=C2)C2)N(C(C3)CC3(CC3)CCN3C(O)=O)C2=O)C=CC=C1 QUHAWAZXXMNVRR-UHFFFAOYSA-N 0.000 description 1
- WFOYHDXDDWGHRY-UHFFFAOYSA-N COC1=C(CN2CC(N(CC2)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=CC=C1OC Chemical compound COC1=C(CN2CC(N(CC2)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=CC=C1OC WFOYHDXDDWGHRY-UHFFFAOYSA-N 0.000 description 1
- BVHWMSFIOMJTGT-UHFFFAOYSA-N COC1=CC=C(CN2CC(N(CC2)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C)C=C1 Chemical compound COC1=CC=C(CN2CC(N(CC2)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C)C=C1 BVHWMSFIOMJTGT-UHFFFAOYSA-N 0.000 description 1
- KWQFUUFJPFQFNB-UHFFFAOYSA-N COC1=CC=C(CN2CC(N(CC2)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)CN2CCOCC2)C=C1 Chemical compound COC1=CC=C(CN2CC(N(CC2)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)CN2CCOCC2)C=C1 KWQFUUFJPFQFNB-UHFFFAOYSA-N 0.000 description 1
- BJXNFSPQPTWTRQ-UHFFFAOYSA-N COC1=CC=C(CN2CC(NCC2)C2=C(CN3CCOCC3)C=CC=C2)C=C1 Chemical compound COC1=CC=C(CN2CC(NCC2)C2=C(CN3CCOCC3)C=CC=C2)C=C1 BJXNFSPQPTWTRQ-UHFFFAOYSA-N 0.000 description 1
- ZCXKPIAFTAMVRT-UHFFFAOYSA-N COC=1C=C(CN2CC(N(CC2)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=C(C=1)OC Chemical compound COC=1C=C(CN2CC(N(CC2)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=C(C=1)OC ZCXKPIAFTAMVRT-UHFFFAOYSA-N 0.000 description 1
- PAXOXJSGQJOLER-UHFFFAOYSA-N COC=1C=C(CN2CC(N(CC2)C2CC3(C2)CCNCC3)C2=C(C=CC=C2)C(C)C)C=CC=1OC Chemical compound COC=1C=C(CN2CC(N(CC2)C2CC3(C2)CCNCC3)C2=C(C=CC=C2)C(C)C)C=CC=1OC PAXOXJSGQJOLER-UHFFFAOYSA-N 0.000 description 1
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 1
- FWUOTERAKNKWBA-UHFFFAOYSA-N ClC1=C(CN2CC(N(CC2)C2CC3(C2)CCNCC3)C2=C(C=CC=C2)C(C)C)C=CC(=C1)OC Chemical compound ClC1=C(CN2CC(N(CC2)C2CC3(C2)CCNCC3)C2=C(C=CC=C2)C(C)C)C=CC(=C1)OC FWUOTERAKNKWBA-UHFFFAOYSA-N 0.000 description 1
- HLWKZCYEZXXJRL-UHFFFAOYSA-N ClC1=CNC2=NC=C(C=C21)OC1=C(C(=O)OC)C=CC(=C1)F Chemical compound ClC1=CNC2=NC=C(C=C21)OC1=C(C(=O)OC)C=CC(=C1)F HLWKZCYEZXXJRL-UHFFFAOYSA-N 0.000 description 1
- IUQXEFYNXLGHAZ-UHFFFAOYSA-N ClC=1C(=C(CN2CC(N(CC2)C2CC3(C2)CCNCC3)C2=C(C=CC=C2)C(C)C)C=CC=1)OC Chemical compound ClC=1C(=C(CN2CC(N(CC2)C2CC3(C2)CCNCC3)C2=C(C=CC=C2)C(C)C)C=CC=1)OC IUQXEFYNXLGHAZ-UHFFFAOYSA-N 0.000 description 1
- IVZRQNYFSPKSDX-UHFFFAOYSA-N ClC=1C=C(CN2CC(N(CC2)C2CC3(C2)CCNCC3)C2=C(C=CC=C2)C(C)C)C=C(C=1OC)OC Chemical compound ClC=1C=C(CN2CC(N(CC2)C2CC3(C2)CCNCC3)C2=C(C=CC=C2)C(C)C)C=C(C=1OC)OC IVZRQNYFSPKSDX-UHFFFAOYSA-N 0.000 description 1
- 229910021589 Copper(I) bromide Inorganic materials 0.000 description 1
- 108700003861 Dominant Genes Proteins 0.000 description 1
- LNHWZJSDVOSXSF-UHFFFAOYSA-N FC1=C(C=C(CN2CC(N(CC2)C2CC3(C2)CCNCC3)C2=C(C=CC=C2)C(C)C)C=C1)OC Chemical compound FC1=C(C=C(CN2CC(N(CC2)C2CC3(C2)CCNCC3)C2=C(C=CC=C2)C(C)C)C=C1)OC LNHWZJSDVOSXSF-UHFFFAOYSA-N 0.000 description 1
- GDKUSJMKVQMZEU-UHFFFAOYSA-N FC1=C(CN2CC(N(CC2)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=CC=C1 Chemical compound FC1=C(CN2CC(N(CC2)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=CC=C1 GDKUSJMKVQMZEU-UHFFFAOYSA-N 0.000 description 1
- JKRDOHKJXDTZBE-UHFFFAOYSA-N FC1=CC=C(CN2CC(N(CC2)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=C1 Chemical compound FC1=CC=C(CN2CC(N(CC2)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=C1 JKRDOHKJXDTZBE-UHFFFAOYSA-N 0.000 description 1
- CCZYBUZZBBFOQA-UHFFFAOYSA-N FC1=CNC2=NC=C(C=C21)O Chemical compound FC1=CNC2=NC=C(C=C21)O CCZYBUZZBBFOQA-UHFFFAOYSA-N 0.000 description 1
- NBVBCPRCFROJQM-UHFFFAOYSA-N FC=1C=C(CN2CC(N(CC2)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=C(C=1)F Chemical compound FC=1C=C(CN2CC(N(CC2)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=C(C=1)F NBVBCPRCFROJQM-UHFFFAOYSA-N 0.000 description 1
- OOXTWTPVXYHNLY-UHFFFAOYSA-N FC=1C=C(CN2CC(N(CC2)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=CC=1 Chemical compound FC=1C=C(CN2CC(N(CC2)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=CC=1 OOXTWTPVXYHNLY-UHFFFAOYSA-N 0.000 description 1
- WFBDVXFAZCYEGZ-UHFFFAOYSA-N FC=1C=C(CN2CC(N(CC2)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=CC=1F Chemical compound FC=1C=C(CN2CC(N(CC2)C2CC3(C2)CCN(CC3)C(=O)OC(C)(C)C)C2=C(C=CC=C2)C(C)C)C=CC=1F WFBDVXFAZCYEGZ-UHFFFAOYSA-N 0.000 description 1
- KVUYGVUQRQTWPK-UHFFFAOYSA-N FC=1C=C(CN2CC(N(CC2)C2CC3(C2)CCNCC3)C2=C(C=CC=C2)C(C)C)C=C(C=1OC)OC Chemical compound FC=1C=C(CN2CC(N(CC2)C2CC3(C2)CCNCC3)C2=C(C=CC=C2)C(C)C)C=C(C=1OC)OC KVUYGVUQRQTWPK-UHFFFAOYSA-N 0.000 description 1
- GHYQMIQTVWLWCC-UHFFFAOYSA-N FC=1C=C(CN2CC(N(CC2)C2CC3(C2)CCNCC3)C2=C(C=CC=C2)C(C)C)C=CC=1OC Chemical compound FC=1C=C(CN2CC(N(CC2)C2CC3(C2)CCNCC3)C2=C(C=CC=C2)C(C)C)C=CC=1OC GHYQMIQTVWLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 239000007818 Grignard reagent Substances 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000872931 Myoporum sandwicense Species 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- MHABMANUFPZXEB-UHFFFAOYSA-N O-demethyl-aloesaponarin I Natural products O=C1C2=CC=CC(O)=C2C(=O)C2=C1C=C(O)C(C(O)=O)=C2C MHABMANUFPZXEB-UHFFFAOYSA-N 0.000 description 1
- VGBVUNHFSZQVDB-UHFFFAOYSA-N O1C2=C(OCC1)C(=CC=C2)C(=O)N1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound O1C2=C(OCC1)C(=CC=C2)C(=O)N1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C VGBVUNHFSZQVDB-UHFFFAOYSA-N 0.000 description 1
- JJWIZNGYCQTMHV-UHFFFAOYSA-N O1C2=C(OCC1)C(=CC=C2)CN1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound O1C2=C(OCC1)C(=CC=C2)CN1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C JJWIZNGYCQTMHV-UHFFFAOYSA-N 0.000 description 1
- ZFPPWTCVLOHABY-UHFFFAOYSA-N O1C2=C(OCC1)C(=CC=C2)CN1CC(N(CC1)C1CC2(CN(C2)C(=O)OC(C)(C)C)C1)C1=C(C=CC=C1)C(C)C Chemical compound O1C2=C(OCC1)C(=CC=C2)CN1CC(N(CC1)C1CC2(CN(C2)C(=O)OC(C)(C)C)C1)C1=C(C=CC=C1)C(C)C ZFPPWTCVLOHABY-UHFFFAOYSA-N 0.000 description 1
- YNNFJMMQKWTNBT-HHHXNRCGSA-N O1C2=C(OCC1)C(=CC=C2)CN1C[C@@H](N(CC1)C1CC2(C1)CCNCC2)C1=C(C=CC=C1)C(C)C Chemical compound O1C2=C(OCC1)C(=CC=C2)CN1C[C@@H](N(CC1)C1CC2(C1)CCNCC2)C1=C(C=CC=C1)C(C)C YNNFJMMQKWTNBT-HHHXNRCGSA-N 0.000 description 1
- IBPMDCLUWJVMNA-RUZDIDTESA-N O1C2=C(OCC1)C(=CC=C2)CN1C[C@@H](N(CC1)C1CC2(CNC2)C1)C1=C(C=CC=C1)C(C)C Chemical compound O1C2=C(OCC1)C(=CC=C2)CN1C[C@@H](N(CC1)C1CC2(CNC2)C1)C1=C(C=CC=C1)C(C)C IBPMDCLUWJVMNA-RUZDIDTESA-N 0.000 description 1
- YNNFJMMQKWTNBT-MHZLTWQESA-N O1C2=C(OCC1)C(=CC=C2)CN1C[C@H](N(CC1)C1CC2(C1)CCNCC2)C1=C(C=CC=C1)C(C)C Chemical compound O1C2=C(OCC1)C(=CC=C2)CN1C[C@H](N(CC1)C1CC2(C1)CCNCC2)C1=C(C=CC=C1)C(C)C YNNFJMMQKWTNBT-MHZLTWQESA-N 0.000 description 1
- IBPMDCLUWJVMNA-VWLOTQADSA-N O1C2=C(OCC1)C(=CC=C2)CN1C[C@H](N(CC1)C1CC2(CNC2)C1)C1=C(C=CC=C1)C(C)C Chemical compound O1C2=C(OCC1)C(=CC=C2)CN1C[C@H](N(CC1)C1CC2(CNC2)C1)C1=C(C=CC=C1)C(C)C IBPMDCLUWJVMNA-VWLOTQADSA-N 0.000 description 1
- RCRVNPWZHTZEJN-UHFFFAOYSA-N O1C2=C(OCC1)C=C(C=C2)CN1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound O1C2=C(OCC1)C=C(C=C2)CN1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C RCRVNPWZHTZEJN-UHFFFAOYSA-N 0.000 description 1
- NUWHTRJYSRRGKD-UHFFFAOYSA-N O1C2=C(OCC1)C=C(C=C2)CN1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound O1C2=C(OCC1)C=C(C=C2)CN1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C NUWHTRJYSRRGKD-UHFFFAOYSA-N 0.000 description 1
- KHXPBXWJZSGZSG-UHFFFAOYSA-N O1C=C(C=C1)CN1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound O1C=C(C=C1)CN1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C KHXPBXWJZSGZSG-UHFFFAOYSA-N 0.000 description 1
- ULVILCOFBDMKFZ-UHFFFAOYSA-N O1C=C(C=C1)CN1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound O1C=C(C=C1)CN1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C ULVILCOFBDMKFZ-UHFFFAOYSA-N 0.000 description 1
- DZOCTOKUPRGNTQ-UHFFFAOYSA-N O1C=CC2=C1C=CC(=C2)CN1CC(N(CC1)C1CC2(C1)CCNCC2)C1=C(C=CC=C1)C(C)C Chemical compound O1C=CC2=C1C=CC(=C2)CN1CC(N(CC1)C1CC2(C1)CCNCC2)C1=C(C=CC=C1)C(C)C DZOCTOKUPRGNTQ-UHFFFAOYSA-N 0.000 description 1
- LURXBSCVIDOUEV-UHFFFAOYSA-N O1CCC(C2=CC=CC=C12)CN1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound O1CCC(C2=CC=CC=C12)CN1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C LURXBSCVIDOUEV-UHFFFAOYSA-N 0.000 description 1
- YTBHGQHUXNQXBI-UHFFFAOYSA-N O1CCCC2=CC(=CC=C12)CN1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound O1CCCC2=CC(=CC=C12)CN1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C YTBHGQHUXNQXBI-UHFFFAOYSA-N 0.000 description 1
- CQDMWYZAWVPXBF-UHFFFAOYSA-N O1CCCC2=CC(=CC=C12)CN1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound O1CCCC2=CC(=CC=C12)CN1CC(N(CC1)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C CQDMWYZAWVPXBF-UHFFFAOYSA-N 0.000 description 1
- 208000004072 Oncogene Addiction Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- LCKABNHEEAGGEY-UHFFFAOYSA-N S1C2=C(C=C1)C(=CC=C2)CN1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound S1C2=C(C=C1)C(=CC=C2)CN1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C LCKABNHEEAGGEY-UHFFFAOYSA-N 0.000 description 1
- KSWGBIMNCBOYDO-UHFFFAOYSA-N S1C2=C(C=C1)C=C(C=C2)CN1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C Chemical compound S1C2=C(C=C1)C=C(C=C2)CN1CC(N(C(C1)=O)C1CC2(C1)CCN(CC2)C(=O)OC(C)(C)C)C1=C(C=CC=C1)C(C)C KSWGBIMNCBOYDO-UHFFFAOYSA-N 0.000 description 1
- 206010041067 Small cell lung cancer Diseases 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- KPCZJLGGXRGYIE-UHFFFAOYSA-N [C]1=CC=CN=C1 Chemical group [C]1=CC=CN=C1 KPCZJLGGXRGYIE-UHFFFAOYSA-N 0.000 description 1
- ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
- 230000005775 apoptotic pathway Effects 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 229950004993 asunercept Drugs 0.000 description 1
- 125000004320 azepan-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 description 1
- 125000004566 azetidin-1-yl group Chemical group N1(CCC1)* 0.000 description 1
- 125000002393 azetidinyl group Chemical group 0.000 description 1
- 125000004266 aziridin-1-yl group Chemical group [H]C1([H])N(*)C1([H])[H] 0.000 description 1
- 125000004267 aziridin-2-yl group Chemical group [H]N1C([H])([H])C1([H])* 0.000 description 1
- 102000055574 bcl-2 Homologous Antagonist-Killer Human genes 0.000 description 1
- 108700039689 bcl-2 Homologous Antagonist-Killer Proteins 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000004533 benzofuran-5-yl group Chemical group O1C=CC2=C1C=CC(=C2)* 0.000 description 1
- 125000004601 benzofurazanyl group Chemical group N1=C2C(=NO1)C(=CC=C2)* 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- WTEPWWCRWNCUNA-UHFFFAOYSA-M benzyl(triphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)CC1=CC=CC=C1 WTEPWWCRWNCUNA-UHFFFAOYSA-M 0.000 description 1
- GPRLTFBKWDERLU-UHFFFAOYSA-N bicyclo[2.2.2]octane Chemical compound C1CC2CCC1CC2 GPRLTFBKWDERLU-UHFFFAOYSA-N 0.000 description 1
- MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical compound C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- UWTDFICHZKXYAC-UHFFFAOYSA-N boron;oxolane Chemical compound [B].C1CCOC1 UWTDFICHZKXYAC-UHFFFAOYSA-N 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- IYYIVELXUANFED-UHFFFAOYSA-N bromo(trimethyl)silane Chemical compound C[Si](C)(C)Br IYYIVELXUANFED-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004296 chiral HPLC Methods 0.000 description 1
- VZWXIQHBIQLMPN-UHFFFAOYSA-N chromane Chemical compound C1=CC=C2CCCOC2=C1 VZWXIQHBIQLMPN-UHFFFAOYSA-N 0.000 description 1
- 125000003016 chromanyl group Chemical group O1C(CCC2=CC=CC=C12)* 0.000 description 1
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012059 conventional drug carrier Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000000392 cycloalkenyl group Chemical group 0.000 description 1
- 125000000000 cycloalkoxy group Chemical group 0.000 description 1
- SHQSVMDWKBRBGB-UHFFFAOYSA-N cyclobutanone Chemical compound O=C1CCC1 SHQSVMDWKBRBGB-UHFFFAOYSA-N 0.000 description 1
- PEOPRURBGPAUJM-UHFFFAOYSA-N cyclohexane formaldehyde Chemical compound C=O.C=O.C1CCCCC1 PEOPRURBGPAUJM-UHFFFAOYSA-N 0.000 description 1
- 125000006547 cyclononyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- DEZRYPDIMOWBDS-UHFFFAOYSA-N dcm dichloromethane Chemical compound ClCCl.ClCCl DEZRYPDIMOWBDS-UHFFFAOYSA-N 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- GRTGGSXWHGKRSB-UHFFFAOYSA-N dichloromethyl methyl ether Chemical compound COC(Cl)Cl GRTGGSXWHGKRSB-UHFFFAOYSA-N 0.000 description 1
- 125000000723 dihydrobenzofuranyl group Chemical group O1C(CC2=C1C=CC=C2)* 0.000 description 1
- 125000004852 dihydrofuranyl group Chemical group O1C(CC=C1)* 0.000 description 1
- 125000005043 dihydropyranyl group Chemical group O1C(CCC=C1)* 0.000 description 1
- 125000004655 dihydropyridinyl group Chemical group N1(CC=CC=C1)* 0.000 description 1
- 125000005057 dihydrothienyl group Chemical group S1C(CC=C1)* 0.000 description 1
- JMRYOSQOYJBDOI-UHFFFAOYSA-N dilithium;di(propan-2-yl)azanide Chemical compound [Li+].CC(C)[N-]C(C)C.CC(C)N([Li])C(C)C JMRYOSQOYJBDOI-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- RHFZTBSULNJWEI-UHFFFAOYSA-N dimethyl 2-(methoxymethylidene)propanedioate Chemical compound COC=C(C(=O)OC)C(=O)OC RHFZTBSULNJWEI-UHFFFAOYSA-N 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- UXGNZZKBCMGWAZ-UHFFFAOYSA-N dimethylformamide dmf Chemical compound CN(C)C=O.CN(C)C=O UXGNZZKBCMGWAZ-UHFFFAOYSA-N 0.000 description 1
- 125000000532 dioxanyl group Chemical group 0.000 description 1
- 125000000597 dioxinyl group Chemical group 0.000 description 1
- 125000005879 dioxolanyl group Chemical group 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- ODCCJTMPMUFERV-UHFFFAOYSA-N ditert-butyl carbonate Chemical compound CC(C)(C)OC(=O)OC(C)(C)C ODCCJTMPMUFERV-UHFFFAOYSA-N 0.000 description 1
- 125000005883 dithianyl group Chemical group 0.000 description 1
- CETRZFQIITUQQL-UHFFFAOYSA-N dmso dimethylsulfoxide Chemical compound CS(C)=O.CS(C)=O CETRZFQIITUQQL-UHFFFAOYSA-N 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- OCLXJTCGWSSVOE-UHFFFAOYSA-N ethanol etoh Chemical compound CCO.CCO OCLXJTCGWSSVOE-UHFFFAOYSA-N 0.000 description 1
- 230000005496 eutectics Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical group C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 125000006379 fluoropyridyl group Chemical group 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 125000004281 furazan-3-yl group Chemical group [H]C1=NON=C1* 0.000 description 1
- 125000003838 furazanyl group Chemical group 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 125000002636 imidazolinyl group Chemical group 0.000 description 1
- 125000004857 imidazopyridinyl group Chemical group N1C(=NC2=C1C=CC=N2)* 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000034727 intrinsic apoptotic signaling pathway Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000010829 isocratic elution Methods 0.000 description 1
- 125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000004498 isoxazol-4-yl group Chemical group O1N=CC(=C1)* 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- DBTNVRCCIDISMV-UHFFFAOYSA-L lithium;magnesium;propane;dichloride Chemical compound [Li+].[Mg+2].[Cl-].[Cl-].C[CH-]C DBTNVRCCIDISMV-UHFFFAOYSA-L 0.000 description 1
- 210000001853 liver microsome Anatomy 0.000 description 1
- 238000003819 low-pressure liquid chromatography Methods 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- OTCKOJUMXQWKQG-UHFFFAOYSA-L magnesium bromide Chemical compound [Mg+2].[Br-].[Br-] OTCKOJUMXQWKQG-UHFFFAOYSA-L 0.000 description 1
- 229910001623 magnesium bromide Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 1
- IUYHWZFSGMZEOG-UHFFFAOYSA-M magnesium;propane;chloride Chemical compound [Mg+2].[Cl-].C[CH-]C IUYHWZFSGMZEOG-UHFFFAOYSA-M 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- COTNUBDHGSIOTA-UHFFFAOYSA-N meoh methanol Chemical compound OC.OC COTNUBDHGSIOTA-UHFFFAOYSA-N 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- YQUHULOBTDYMAG-UHFFFAOYSA-N methyl 2,4-difluorobenzoate Chemical compound COC(=O)C1=CC=C(F)C=C1F YQUHULOBTDYMAG-UHFFFAOYSA-N 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 125000005322 morpholin-1-yl group Chemical group 0.000 description 1
- 125000004312 morpholin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])OC([H])(*)C1([H])[H] 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- PEECTLLHENGOKU-UHFFFAOYSA-N n,n-dimethylpyridin-4-amine Chemical compound CN(C)C1=CC=NC=C1.CN(C)C1=CC=NC=C1 PEECTLLHENGOKU-UHFFFAOYSA-N 0.000 description 1
- WOOWBQQQJXZGIE-UHFFFAOYSA-N n-ethyl-n-propan-2-ylpropan-2-amine Chemical compound CCN(C(C)C)C(C)C.CCN(C(C)C)C(C)C WOOWBQQQJXZGIE-UHFFFAOYSA-N 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- JLYAXFNOILIKPP-KXQOOQHDSA-N navitoclax Chemical compound C([C@@H](NC1=CC=C(C=C1S(=O)(=O)C(F)(F)F)S(=O)(=O)NC(=O)C1=CC=C(C=C1)N1CCN(CC1)CC1=C(CCC(C1)(C)C)C=1C=CC(Cl)=CC=1)CSC=1C=CC=CC=1)CN1CCOCC1 JLYAXFNOILIKPP-KXQOOQHDSA-N 0.000 description 1
- 229950004847 navitoclax Drugs 0.000 description 1
- 230000006654 negative regulation of apoptotic process Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 125000005061 octahydroisoindolyl group Chemical group C1(NCC2CCCCC12)* 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- JMJRYTGVHCAYCT-UHFFFAOYSA-N oxan-4-one Chemical compound O=C1CCOCC1 JMJRYTGVHCAYCT-UHFFFAOYSA-N 0.000 description 1
- CXLGNJCMPWUZKM-UHFFFAOYSA-N oxane-4-carbaldehyde Chemical compound O=CC1CCOCC1 CXLGNJCMPWUZKM-UHFFFAOYSA-N 0.000 description 1
- 125000004304 oxazol-5-yl group Chemical group O1C=NC=C1* 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000003585 oxepinyl group Chemical group 0.000 description 1
- 125000004274 oxetan-2-yl group Chemical group [H]C1([H])OC([H])(*)C1([H])[H] 0.000 description 1
- 125000000466 oxiranyl group Chemical group 0.000 description 1
- JLPJFSCQKHRSQR-UHFFFAOYSA-N oxolan-3-one Chemical compound O=C1CCOC1 JLPJFSCQKHRSQR-UHFFFAOYSA-N 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 1
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 1
- YZTJYBJCZXZGCT-UHFFFAOYSA-N phenylpiperazine Chemical group C1CNCCN1C1=CC=CC=C1 YZTJYBJCZXZGCT-UHFFFAOYSA-N 0.000 description 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000006659 positive regulation of apoptotic process Effects 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012746 preparative thin layer chromatography Methods 0.000 description 1
- VVWRJUBEIPHGQF-MDZDMXLPSA-N propan-2-yl (ne)-n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)\N=N\C(=O)OC(C)C VVWRJUBEIPHGQF-MDZDMXLPSA-N 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 125000001042 pteridinyl group Chemical group N1=C(N=CC2=NC=CN=C12)* 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 125000004290 pyrazolidin-3-yl group Chemical group [H]N1N([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000002755 pyrazolinyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 description 1
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 description 1
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 description 1
- YBBJKCMMCRQZMA-UHFFFAOYSA-N pyrithione Chemical compound ON1C=CC=CC1=S YBBJKCMMCRQZMA-UHFFFAOYSA-N 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 239000012363 selectfluor Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 208000000587 small cell lung carcinoma Diseases 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 239000012321 sodium triacetoxyborohydride Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- DHHKPEUQJIEKOA-UHFFFAOYSA-N tert-butyl 2-[6-(nitromethyl)-6-bicyclo[3.2.0]hept-3-enyl]acetate Chemical group C1C=CC2C(CC(=O)OC(C)(C)C)(C[N+]([O-])=O)CC21 DHHKPEUQJIEKOA-UHFFFAOYSA-N 0.000 description 1
- WHRNULOCNSKMGB-UHFFFAOYSA-N tetrahydrofuran thf Chemical compound C1CCOC1.C1CCOC1 WHRNULOCNSKMGB-UHFFFAOYSA-N 0.000 description 1
- 125000004192 tetrahydrofuran-2-yl group Chemical group [H]C1([H])OC([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000004187 tetrahydropyran-2-yl group Chemical group [H]C1([H])OC([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000004853 tetrahydropyridinyl group Chemical group N1(CCCC=C1)* 0.000 description 1
- 125000005958 tetrahydrothienyl group Chemical group 0.000 description 1
- 125000004632 tetrahydrothiopyranyl group Chemical group S1C(CCCC1)* 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 125000001583 thiepanyl group Chemical group 0.000 description 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- YNVOMSDITJMNET-UHFFFAOYSA-N thiophene-3-carboxylic acid Chemical compound OC(=O)C=1C=CSC=1 YNVOMSDITJMNET-UHFFFAOYSA-N 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- CFOAUYCPAUGDFF-UHFFFAOYSA-N tosmic Chemical compound CC1=CC=C(S(=O)(=O)C[N+]#[C-])C=C1 CFOAUYCPAUGDFF-UHFFFAOYSA-N 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
- CSRZQMIRAZTJOY-UHFFFAOYSA-N trimethylsilyl iodide Substances C[Si](C)(C)I CSRZQMIRAZTJOY-UHFFFAOYSA-N 0.000 description 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- LQBVNQSMGBZMKD-UHFFFAOYSA-N venetoclax Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NCC1CCOCC1 LQBVNQSMGBZMKD-UHFFFAOYSA-N 0.000 description 1
- 229960001183 venetoclax Drugs 0.000 description 1
- PXXNTAGJWPJAGM-UHFFFAOYSA-N vertaline Natural products C1C2C=3C=C(OC)C(OC)=CC=3OC(C=C3)=CC=C3CCC(=O)OC1CC1N2CCCC1 PXXNTAGJWPJAGM-UHFFFAOYSA-N 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2020084992 | 2020-04-15 | ||
CNPCT/CN2020/084992 | 2020-04-15 | ||
CN2020100472 | 2020-07-06 | ||
CNPCT/CN2020/100472 | 2020-07-06 | ||
CNPCT/CN2020/125580 | 2020-10-30 | ||
CN2020125580 | 2020-10-30 | ||
CNPCT/CN2021/075831 | 2021-02-07 | ||
CN2021075831 | 2021-02-07 | ||
CN2021086189 | 2021-04-09 | ||
CNPCT/CN2021/086189 | 2021-04-09 | ||
PCT/CN2021/087225 WO2021208963A1 (en) | 2020-04-15 | 2021-04-14 | Bcl-2 inhibitor |
CN202180029718.1A CN116802179A (zh) | 2020-04-15 | 2021-04-14 | Bcl-2抑制剂 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202180029718.1A Division CN116802179A (zh) | 2020-04-15 | 2021-04-14 | Bcl-2抑制剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116969937A true CN116969937A (zh) | 2023-10-31 |
Family
ID=78083530
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310560508.6A Pending CN116969937A (zh) | 2020-04-15 | 2021-04-14 | Bcl-2抑制剂 |
CN202180029718.1A Pending CN116802179A (zh) | 2020-04-15 | 2021-04-14 | Bcl-2抑制剂 |
CN202310559385.4A Pending CN116969936A (zh) | 2020-04-15 | 2021-04-14 | Bcl-2抑制剂 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202180029718.1A Pending CN116802179A (zh) | 2020-04-15 | 2021-04-14 | Bcl-2抑制剂 |
CN202310559385.4A Pending CN116969936A (zh) | 2020-04-15 | 2021-04-14 | Bcl-2抑制剂 |
Country Status (13)
Country | Link |
---|---|
US (1) | US20230159522A1 (de) |
EP (1) | EP4136084A4 (de) |
JP (1) | JP2023520843A (de) |
KR (1) | KR20230002419A (de) |
CN (3) | CN116969937A (de) |
AU (1) | AU2021256580A1 (de) |
BR (1) | BR112022019525A2 (de) |
CA (1) | CA3172478A1 (de) |
IL (1) | IL296582A (de) |
MX (1) | MX2022013006A (de) |
TW (1) | TW202200574A (de) |
WO (1) | WO2021208963A1 (de) |
ZA (1) | ZA202209891B (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116981668A (zh) * | 2021-04-09 | 2023-10-31 | 百济神州(北京)生物科技有限公司 | 制备bcl-2抑制剂的中间体的方法 |
WO2023078398A1 (en) * | 2021-11-05 | 2023-05-11 | Fochon Pharmaceuticals, Ltd. | Compounds as bcl-2 inhibitors |
WO2023088167A1 (en) * | 2021-11-20 | 2023-05-25 | Fochon Pharmaceuticals, Ltd. | Compounds as bcl-2 inhibitors |
WO2023104043A1 (zh) * | 2021-12-06 | 2023-06-15 | 杭州和正医药有限公司 | 一种抗凋亡蛋白bcl-2抑制剂、药物组合物及其应用 |
WO2023122000A1 (en) * | 2021-12-20 | 2023-06-29 | Newave Pharmaceutical Inc. | Bcl-2 inhibitors |
CN114292192A (zh) * | 2022-01-17 | 2022-04-08 | 山东泓瑞医药科技股份公司 | 一种3,4-二甲氧基苯甲酸甲酯的合成方法 |
WO2023231777A1 (en) * | 2022-06-01 | 2023-12-07 | Fochon Pharmaceuticals, Ltd. | Compounds as bcl-2 inhibitors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106749233B (zh) * | 2016-11-24 | 2020-04-21 | 中山大学 | 一类磺酰胺衍生物及其应用 |
EP3788042A4 (de) * | 2018-04-29 | 2022-01-26 | BeiGene, Ltd. | Bcl-2-inhibitoren |
US20220073513A1 (en) * | 2018-12-29 | 2022-03-10 | Newave Pharmaceutical Inc. | 1h-pyrrolo[2,3-b]pyridine derivatives and related compounds as bcl-2 inhibitors for the treatment of neoplastic and autoimmune diseases |
CN116981668A (zh) * | 2021-04-09 | 2023-10-31 | 百济神州(北京)生物科技有限公司 | 制备bcl-2抑制剂的中间体的方法 |
-
2021
- 2021-04-14 IL IL296582A patent/IL296582A/en unknown
- 2021-04-14 AU AU2021256580A patent/AU2021256580A1/en active Pending
- 2021-04-14 WO PCT/CN2021/087225 patent/WO2021208963A1/en active Application Filing
- 2021-04-14 MX MX2022013006A patent/MX2022013006A/es unknown
- 2021-04-14 CA CA3172478A patent/CA3172478A1/en active Pending
- 2021-04-14 BR BR112022019525A patent/BR112022019525A2/pt unknown
- 2021-04-14 CN CN202310560508.6A patent/CN116969937A/zh active Pending
- 2021-04-14 CN CN202180029718.1A patent/CN116802179A/zh active Pending
- 2021-04-14 US US17/916,845 patent/US20230159522A1/en active Pending
- 2021-04-14 JP JP2022554627A patent/JP2023520843A/ja active Pending
- 2021-04-14 CN CN202310559385.4A patent/CN116969936A/zh active Pending
- 2021-04-14 EP EP21789482.3A patent/EP4136084A4/de active Pending
- 2021-04-14 KR KR1020227035815A patent/KR20230002419A/ko active Search and Examination
- 2021-04-14 TW TW110113455A patent/TW202200574A/zh unknown
-
2022
- 2022-09-05 ZA ZA2022/09891A patent/ZA202209891B/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20230159522A1 (en) | 2023-05-25 |
AU2021256580A1 (en) | 2022-09-29 |
CN116802179A (zh) | 2023-09-22 |
WO2021208963A1 (en) | 2021-10-21 |
MX2022013006A (es) | 2023-01-11 |
IL296582A (en) | 2022-11-01 |
KR20230002419A (ko) | 2023-01-05 |
CA3172478A1 (en) | 2021-10-21 |
EP4136084A4 (de) | 2023-11-01 |
CN116969936A (zh) | 2023-10-31 |
EP4136084A1 (de) | 2023-02-22 |
BR112022019525A2 (pt) | 2023-11-14 |
ZA202209891B (en) | 2023-05-31 |
TW202200574A (zh) | 2022-01-01 |
JP2023520843A (ja) | 2023-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN116969937A (zh) | Bcl-2抑制剂 | |
US10233186B2 (en) | Inhibitors of activin receptor-like kinase | |
AU2016311426B2 (en) | Compounds and compositions useful for treating disorders related to NTRK | |
CN109715634B (zh) | Menin-mll相互作用的稠合二环抑制剂 | |
WO2019210828A1 (en) | Bcl-2 INHIBITORS | |
TWI408135B (zh) | 腎外髓質鉀通道抑制劑 | |
EP3027616B1 (de) | Azaindolverbindungen als rorc-modulatoren | |
JP7097373B2 (ja) | キナーゼ阻害剤としてのアミノトリアゾロピリジン | |
BRPI0817843B1 (pt) | inibidores da quinase c-fms, composição farmacêutica que os compreende e processo para a fabricação da dita composição | |
EA036630B1 (ru) | Бициклические производные | |
CA2922933A1 (en) | 2,8-diazaspiro[4.5]decane and 3,9-dispiro[5.5]undecane derivates and pharmaceutical compositions thereof useful as tryptophan hydroxylase inhibitors | |
JP2011521888A (ja) | グレリン受容体の調節因子としてのn−フェニルヒドラジド誘導体 | |
CN113454086A (zh) | 作为tlr7激动剂的咪唑并[2,1-f][1,2,4]三嗪-4-胺衍生物 | |
WO2016100166A1 (en) | SUBSTITUTED DIHYDRO-1H-PYRROLO[3,2-c]PYRIDIN-4(5H)-ONES AS RIPK3 INHIBITORS | |
WO2008100618A2 (en) | Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s | |
CA3180803A1 (en) | Condensed substituted hydropyrroles as antagonists of the muscarinic acetylcholine receptor m4 | |
KR20190026917A (ko) | 아미노피리딘 유도체 및 이의 선택적 alk-2 억제제로서의 용도 | |
CN114805311A (zh) | 螺环茚 | |
EP4072678A1 (de) | Antagonisten des muskarinischen acetylcholinrezeptors m4 | |
EP4055013B1 (de) | Wdr5-inhibitoren und modulatoren | |
AU2021253584A1 (en) | Kinase inhibitors | |
TW202134213A (zh) | 具有水解磷脂酸受體作動活性之化合物及其醫藥用途 | |
KR102614279B1 (ko) | 테트라히드로옥세피노피리딘 화합물 | |
WO2023249872A1 (en) | Substituted fused bicyclic compounds and related methods of treatment | |
CN116981458A (zh) | 具有四氢吲哚-1-甲酰胺作为bcl-2抑制剂的化合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |